{"Title": ["2 Biotech Stocks With Major Incoming Catalysts", "3 \u201cStrong Buy\u201d Healthcare Stocks That Should Remain Healthy", "Interesting ACAD Put And Call Options For July 24th", "Is Acadia Pharmaceuticals a Buy?", "Now\u2019s the Time to Buy These 3 Stocks", "ACAD July 10th Options Begin Trading", "Interesting ACAD Put And Call Options For July 2nd", "Analysts Predict 11% Gains Ahead For The Holdings of IYH", "2 Biotech Stocks With Major Incoming Catalysts", "Is Axsome Therapeutics a Screaming Buy?", "Acadia Pharmaceuticals (ACAD) Q1 2020 Earnings Call Transcript", "10 Stocks to Buy for an Aging Population", "Implied RXL Analyst Target Price: $112", "Interesting ACAD Put And Call Options For May 1st", "This 1 Stock Is a Good Buy During the Coronavirus Sell-Off", "Acadia Pharmaceuticals Breaks Below 200-Day Moving Average - Notable for ACAD", "Is Amarin Stock a Buy?", "Is Axsome Therapeutics a Screaming Buy?", "Acadia Pharmaceuticals (ACAD) Q4 2019 Earnings Call Transcript", "Notable Tuesday Option Activity: ACAD, KNX, EXPE", "Noteworthy Thursday Option Activity: AVGO, ACAD, GDDY", "3 Top Biotech Stocks to Buy Right Now", "Interesting ACAD Put And Call Options For March 6th", "Add Up The Parts: FBT Could Be Worth $182", "6 Quality Biotech Stocks on Sale Now", "First Week of April 9th Options Trading For Acadia Pharmaceuticals (ACAD)", "ACAD February 28th Options Begin Trading", "The 10 Best Healthcare Stocks of the Decade", "Where Will GW Pharmaceuticals Be in 5 Years?", "2 Biotech Stocks Poised to Soar in 2020", "3 Stocks That Could Be the Next Biotech Buyouts", "Acadia Pharmaceuticals Larger Than S&P 500 Component Flowserve Corp", "Save Yourself the Migraine and Buy This 1 Pharma Stock Now", "Health Care Sector Update for 12/05/2019: AUPH, ACAD, SAGE, JNJ, PFE, ABT, MRK, AMGN", "Why Acadia Pharmaceuticals Stock Is on Fire Today", "AUPH Soars On Lupus Trial Results, ACAD On Watch, ALNA Trims Workforce", "7 Exciting Biotech Stocks to Buy Now", "3 Monster Growth Stocks That Are Still in the Buy Zone", "Interesting ACAD Put And Call Options For January 2020", "Analysts Expect FBT Will Reach $179", "IYH's Holdings Imply 12% Gain Potential", "Is Acadia Pharmaceuticals Stock Now a Buy?", "Acadia Pharmaceuticals Delivers Record Q3 Revenue, Fueled by Antipsychotic Drug Nuplazid", "Acadia Pharmaceuticals (ACAD) Q3 2019 Earnings Call Transcript", "3 Mid-Cap Biotech Stocks To Consider Buying Now", "Here's Why Acadia Pharmaceuticals Jumped 30.1% in September", "November 8th Options Now Available For Acadia Pharmaceuticals (ACAD)", "Notable Wednesday Option Activity: ACAD, SPWR, ZS", "Health Care Sector Update for 09/23/2019: ACAD,AKCA,PSTV,CMD", "How Doctors Treat Dementia and Lung Cancer Could Be About to Change", "5 Top Stock Trades for Wednesday: BA, ACB, PINS", "3 Biotech Stocks That Soared Last Week", "Does Acadia Pharmaceuticals Have More Room to Run?", "Is Acadia Pharmaceuticals a Good Biotech Stock to Buy Now?", "6 Top Gainers In Healthcare Sector (ACAD, ARDX, KOOL\u2026)", "FBT, ACAD, UTHR, NBIX: ETF Outflow Alert", "Health Care Sector Update for 09/23/2019: ACAD,AKCA,PSTV,CMD", "Health Care Sector Update for 09/09/2019: ACHC,ACAD,RGEN", "Health Care Sector Update for 09/09/2019: ACAD, AXNX, AMGN, JNJ, PFE, ABT, MRK", "Acadia Pharmaceuticals (ACAD) Shares Cross Below 200 DMA", "October 25th Options Now Available For Acadia Pharmaceuticals (ACAD)", "Look Under The Hood: VB Has 16% Upside", "Why Acadia Pharmaceuticals Stock Skyrocketed Today", "ACAD October 4th Options Begin Trading", "First Week of October 18th Options Trading For Acadia Pharmaceuticals (ACAD)", "First Week of March 2020 Options Trading For Acadia Pharmaceuticals (ACAD)", "Health Care Sector Update for 08/01/2019: SYRS,MYGN,ACAD,ABMD", "Health Care Sector Update for 08/01/2019: MYGN,ACAD,ABMD", "Why Acadia Pharmaceuticals Stock Is Crushing It Today", "Acadia Pharmaceuticals Beats Expectations in Q2", "October 11th Options Now Available For Acadia Pharmaceuticals (ACAD)", "RSI Alert: Acadia Pharmaceuticals (ACAD) Now Oversold", "Acadia Pharmaceuticals Breaks Below 200-Day Moving Average - Notable for ACAD", "Why Acadia Pharmaceuticals Is Tanking Today", "Are These 2 Beaten-Down Biotech Stocks Worth Buying?", "Interesting ACAD Put And Call Options For July 19th", "JKK's Holdings Imply 14% Gain Potential", "First Week of September 20th Options Trading For Acadia Pharmaceuticals (ACAD)", "Acadia Pharmaceuticals (ACAD) Q2 2019 Earnings Call Transcript", "RSI Alert: Acadia Pharmaceuticals (ACAD) Now Oversold", "June 14th Options Now Available For Acadia Pharmaceuticals (ACAD)", "Acadia Pharmaceuticals (ACAD) Q1 2019 Earnings Call Transcript", "3 Biotech Stocks That Doubled After Hitting Bottom in 2018", "Notable ETF Inflow Detected - FBT, IONS, RARE, ACAD", "Why Acadia Pharmaceuticals Stock Perked Up in February", "Interesting ACAD Put And Call Options For July 5th", "Wednesday's ETF Movers: FBT, IHF", "Acadia Pharmaceuticals Inc (ACAD) Q4 2018 Earnings Conference Call Transcript", "Earnings Reaction History: ACADIA PHARMA, 54.5% Follow-Through Indicator, 8.5% Sensitive", "What's in the Cards for Bausch Health (BHC) Q4 Earnings?", "5 Drug/Biotech Stocks Set to Beat Estimates in Q4 Earnings", "Zoetis (ZTS) to Report Q4 Earnings: What's in the Cards?", "Is a Disappointment in Store for Incyte (INCY) Q4 Earnings?", "Noteworthy Thursday Option Activity: FRO, ULTA, ACAD", "The Smartest People on Wall Street Are Buying These 3 Stocks -- Should You?", "Will Gilead (GILD) Q4 Earnings Disappoint on Weak HCV Sales?", "Is a Beat in Store for Vertex (VRTX) This Earnings Season?", "MacroGenics Up on Lifting of Partial Hold on Cancer Candidate", "Will ACADIA Pharmaceuticals Continue to Surge Higher?", "Amgen's Postmenopausal Osteoporosis Drug Gets FDA Panel Nod", "First Week of ACAD March 1st Options Trading", "Tilray (TLRY) to Report Q4 Earnings: What's in the Cards?", "Here's Why ACADIA Pharmaceuticals Dropped 15.2% in December", "Acadia Pharmaceuticals Becomes Oversold (ACAD)", "Acadia Pharmaceuticals Breaks Above 200-Day Moving Average - Bullish for ACAD", "ACAD January 2019 Options Begin Trading", "Here's Why Acadia Pharmaceuticals Is Soaring", "XBI, ACAD, TSRO, IONS: ETF Outflow Alert", "Health Care Sector Update for 11/27/2018: HALO,GTHX,ACAD", "Thursday's ETF Movers: FBT, GDXJ", "Why Acadia Pharmaceuticals Is Plummeting", "Health Care Sector Update for 11/27/2018: VRTX,HALO,GTHX,ACAD", "Noteworthy ETF Outflows: XBI, ACAD, IONS, ARRY", "December 28th Options Now Available For Acadia Pharmaceuticals (ACAD)", "Acadia Pharmaceuticals (ACAD) Reports Q3 Loss, Tops Revenue Estimates", "Earnings Reaction History: ACADIA Pharmaceuticals Inc, 60.0% Follow-Through Indicator, 8.5% Sensitive", "Noteworthy ETF Inflows: XBI, ACAD, ARRY, VKTX", "Health Care Sector Update for 11/27/2018: DVA,VRTX,ACAD,GTHX", "Earnings Preview: Acadia Pharmaceuticals (ACAD) Q3 Earnings Expected to Decline", "Here's Why ACADIA Pharmaceuticals Jumped 46% in September", "Noteworthy Thursday Option Activity: ACAD, CL, INGN", "5 Top Healthcare Mutual Funds to Buy in October", "5 Best Biotech Stocks to Buy In October", "Interesting ACAD Put And Call Options For November 9th", "Biotech Stock Roundup: ALXN Soliris Successful, Respite For Sarepta, AMRN Soars", "ACAD Makes Notable Cross Below Critical Moving Average", "3 Biotech Stocks That Soared This Week: Are They Buys?", "FDA Confirms Positive Safety Profile of Acadia's Nuplazid", "Here's Why Acadia Pharmaceuticals Inc. Spiked Over 26% Today", "Noteworthy Friday Option Activity: FDX, WYNN, ACAD", "Health Care Sector Update for 09/10/2018: ACAD,MRK,FOLD", "Health Care Sector Update for 09/10/2018: MYOK, ACAD, MRK, FOLD, LLY", "Better Speculative Biotech Stock: Amarin Corporation vs. Geron Corporation", "Bullish Two Hundred Day Moving Average Cross - ACAD", "After Hours Most Active for Aug 9, 2018 : ABEV, QQQ, VER, BRK/B, F, DBX, KMI, WFC, ACAD, GRPN, EA, OSTK", "Acadia Pharmaceuticals (ACAD) Reports Q2 Loss, Lags Revenue Estimates", "Will ACADIA (ACAD) Disappoint Investors in Q2 Earnings?", "5 Big Pharma Stocks Investors Love Right Now", "Better Buy: Acadia Pharmaceuticals vs. Eli Lilly", "Dopamine and the Weather, Part 2", "ACAD August 31st Options Begin Trading", "Why Acadia Pharmaceuticals Stock Is Tanking Today", "After Hours Most Active for Aug 9, 2018 : ABEV, QQQ, VER, BRK/B, F, DBX, KMI, WFC, ACAD, GRPN, EA, OSTK", "Acadia Pharmaceuticals (ACAD) Reports Q2 Loss, Lags Revenue Estimates", "Will ACADIA (ACAD) Disappoint Investors in Q2 Earnings?", "5 Big Pharma Stocks Investors Love Right Now", "Better Buy: Acadia Pharmaceuticals vs. Biogen", "Interesting ACAD Put And Call Options For June 29th", "Why ACADIA Pharmaceuticals Stock Is Falling Today", "The 3 Worst Biotech Stocks of 2018 (So Far)", "Why Acadia Pharmaceuticals Is Soaring Today", "Noteworthy Thursday Option Activity: ACAD, ETSY, INSY", "July 27th Options Now Available For Acadia Pharmaceuticals (ACAD)", "Is Acadia Pharmaceuticals (ACAD) a Buy?", "Better Buy: Acadia Pharmaceuticals vs. Biogen", "Interesting ACAD Put And Call Options For June 29th", "Why ACADIA Pharmaceuticals Stock Is Falling Today", "ACADIA Posts Narrower than Expected Loss in Q1, Sales Beat", "Earnings Reaction History: ACADIA Pharmaceuticals Inc, 66.7% Follow-Through Indicator, 9.2% Sensitive", "Why Acadia Pharmaceuticals Jumped 11% Higher Today", "Health Care Sector Update for 05/04/2018: SRPT, ACAD, PTLA, CELG", "Health Care Sector Update for 05/04/2018: ACAD,PTLA,CELG", "Will ACADIA (ACAD) Disappoint Investors This Earnings Season?", "Health Care Sector Update for 04/27/2018: ACAD,GILD,HRC,SNY", "Are These 2 Biotech Laggards Ready to Rebound?", "Mid-Afternoon Market Update: Crude Oil Up Over 2%; Therapix Biosciences Shares Spike Higher", "Better Buy: Acadia Pharmaceuticals vs. Eli Lilly", "ACAD May 11th Options Begin Trading", "Is Acadia Pharmaceuticals a Buy?", "Is Acadia Pharmaceuticals Stock Now a Strong Buy?", "Interesting ACAD Put And Call Options For April 27th", "Why Acadia Pharmaceuticals Stock Is Crashing Today", "Mid-Afternoon Market Update: Crude Oil Up Over 2%; Therapix Biosciences Shares Spike Higher", "Mid-Afternoon Market Update: Crude Oil Up Over 2%; Therapix Biosciences Shares Spike Higher", "Better Buy: Acadia Pharmaceuticals vs. Eli Lilly", "ACAD May 11th Options Begin Trading", "Will ACADIA (ACAD) Disappoint Investors in Q4 Earnings?", "Interesting ACAD Put And Call Options For April 20th", "Interesting ACAD Put And Call Options For March 29th", "Noteworthy Tuesday Option Activity: TSLA, HD, ACAD", "Mid-Morning Market Update: Markets Open Higher; Lowe's Profit Misses Views", "Earnings Reaction History: ACADIA Pharmaceuticals Inc, 62.5% Follow-Through Indicator, 8.3% Sensitive", "Interesting ACAD Put And Call Options For April 6th", "George Soros Just Dumped These 2 Healthcare Stocks. Should You?", "Will ACADIA (ACAD) Disappoint Investors in Q4 Earnings?", "TherapeuticsMD Submits NDA for VMS Candidate, Shares Rise", "The Zacks Analyst Blog Highlights: ACADIA Pharmaceuticals, Sangamo Therapeutics, AnaptysBio and Sino Biopharmaceutical", "March 23rd Options Now Available For Acadia Pharmaceuticals (ACAD)", "Why the Earnings Streak Will Continue for ACADIA Pharmaceuticals (ACAD)", "Minerva Initiates Phase III Study on Schizophrenia Candidate", "First Week of ACAD February 2018 Options Trading", "TherapeuticsMD Falls Despite Acceptance of NDA: Here's Why", "Shire's New Formulation of Oncaspar Gets Approval in Europe", "Glaxo's Nucala Label Expansion Application Gets FDA Approval", "Proteostasis Stock Surges on Positive Data From CF Studies", "4 Biotech Stocks Ready to Crush the Market in 2018", "Why the Earnings Streak Will Continue for ACADIA Pharmaceuticals (ACAD)", "Minerva Initiates Phase III Study on Schizophrenia Candidate", "First Week of ACAD February 2018 Options Trading", "TherapeuticsMD Falls Despite Acceptance of NDA: Here's Why", "Shire's New Formulation of Oncaspar Gets Approval in Europe", "Analysts Anticipate 21% Upside For The Holdings of BBH", "Better Buy: Acadia Pharmaceuticals vs. Biogen", "Lilly Reports Mixed Results from Late-Stage Cyramza Study", "5 Cheap Biotech Stocks to Snag on the Bounce", "Here's How Acadia Pharmaceuticals Crushed It in 2017", "Medicines Company to Sell Infectious Disease Unit to Melinta", "Spectrum Doubles in 3 Months: What's Driving the Rally?", "ACAD January 2018 Options Begin Trading", "What's in the Cards for Adverum (ADVM) This Earnings Season?", "Acadia Pharmaceuticals Scores Relative Strength Rating Upgrade; Hits Key Threshold", "Acadia Pharmaceuticals is Now Oversold (ACAD)", "How to Invest in Biotech Stocks", "Nektar, Acadia Pop On Street-Crushing Quarters, But Tesaro Dips", "Earnings Reaction History: ACADIA Pharmaceuticals Inc, 62.5% Follow-Through Indicator, 7.0% Sensitive", "Acadia Pharmaceuticals Breaks Below 200-Day Moving Average - Notable for ACAD", "What's in the Cards for Prothena (PRTA) in Q3 Earnings?", "What to Expect from Keryx (KERX) This Earnings Season?", "Horizon Pharma (HZNP) Q3 Earnings: A Disappointment in Store? (revised)", "What's in the Cards for Arena (ARNA) This Earnings Season?", "Ball Corporation (BLL) to Post Q3 Earnings: What to Expect?", "Implied FXH Analyst Target Price: $74", "Lilly's Verzenio Gets Priority Review in First-Line Setting", "Here's Why Intercept (ICPT) Stock Lost 37% So Far in 2017", "Allergan's Uterine Fibroids Candidate's NDA Accepted by FDA", "Why Should You Invest in Novo Nordisk (NVO) Stock Right Now", "Is a Beat in Store for Zoetis (ZTS) This Earnings Season?", "What's in the Cards for Arena (ARNA) This Earnings Season?", "Ball Corporation (BLL) to Post Q3 Earnings: What to Expect?", "Roche (RHHBY) Receives FDA Approval For Cobas Zika Test", "This Biotech Rockets \u2014 Then Dips \u2014 After FDA Breakthrough Win", "ACADIA's Antipsychotic Drug Gets Breakthrough Therapy Status", "Ligand (LGND) Signs Deal to Acquire Crystal Bioscience", "Morning Movers: Constellation Brands Jumps, Biogen Bounces, Celgene Slips", "Mallinckrodt to Begin Sarcoidosis Study on Acthar Gel", "Emergent Completes Acquisition of Anthrax Drug Raxibacumab", "2 Stocks Move in After-Hours Trading", "Acadia Pharma Stock Rockets On Drug Breakthrough Nod", "Noteworthy Friday Option Activity: GRA, DDD, ACAD", "Allergan Authorizes New $2B Share Buyback Plan, Stock Up", "Commit To Buy Acadia Pharmaceuticals At $25, Earn 8.2% Using Options", "Glaxo-Innoviva's Triple Combo Inhaler Positive in Phase III", "Celsion's Immunotherapy Candidate Impresses, Stock Surges", "Supernus Drops SPN-810's Lower Dose Test in Phase III Trials", "Glaxo/Innoviva's Triple Combo Therapy Gets FDA Nod for COPD", "BioMarin Says FDA Not Planning an AdCom for Pegvaliase BLA", "The Math Shows FBT Can Go To $140", "Alexion (ALXN) Reports Interim Results for Soliris Study", "GTx's (GTXI) Enobosarm Positive in Phase II, Shares Down", "Perrigo's Stock Up, Starboard's CEO Calls it a Key Pick", "Billionaires Are Gobbling Up This Beaten-Down Biotech Stock: Should You?", "Supernus Drops SPN-810's Lower Dose Test in Phase III Trials", "Glaxo/Innoviva's Triple Combo Therapy Gets FDA Nod for COPD", "BioMarin Says FDA Not Planning an AdCom for Pegvaliase BLA", "The Math Shows FBT Can Go To $140", "Alexion (ALXN) Reports Interim Results for Soliris Study", "GTx's (GTXI) Enobosarm Positive in Phase II, Shares Down", "Perrigo's Stock Up, Starboard's CEO Calls it a Key Pick", "Marinus Stock Surges on Successful Phase II Epilepsy Study", "Ultragenyx's Burosumab Positive in Phase II for XLH and TIO", "Minerva-J&J's Amendment of MIN-202 Contract Wins EU Approval", "3 Stocks That Turned $8,000 Into at Least $138,000 in 5 Years", "Adamas (ADMS) Dyskinesia Drug Gets FDA Approval, Stock Soars", "Ultragenyx Files BLA to FDA for Hypophosphatemia Candidate", "Kite Pharma at New 52-Week High: What's Driving the Stock?", "Ultragenyx (RARE) Posts Disappointing Phase III Ace-ER Data", "The Medicines Co's Inclisiran Positive in Extension Study", "J&J's (JNJ) Xarelto/Aspirin Regimen Positive in Phase III", "Minerva-J&J's Amendment of MIN-202 Contract Wins EU Approval", "Geron's (GERN) Imetelstat Progressing Well, Setbacks Concern", "Analysts Forecast 10% Gains Ahead For VXF", "Here's Why Acadia Pharmaceuticals Inc. Is Soaring Today", "Drug Stocks Q2 Earnings Roster for Aug 8: ACAD, JAZZ & More", "Will ACADIA (ACAD) Pull Off a Surprise this Earnings Season?", "Jazz Pharmaceuticals Arm Announces $500M Senior Notes Offer", "The Math Shows BBH Can Go To $140", "Minerva On Track to Initiate Phase III Schizophrenia Study", "3 Biotech Stocks for Enterprising Investors", "3 Value Stocks You Haven't Thought Of", "Baker Bros. Advisors Lp Buys Incyte Corp, AveXis Inc, La Jolla Pharmaceutical Co, Sells AbbVie ...", "Sum Up The Pieces: BBH Could Be Worth $138", "Wednesday's ETF Movers: GDXJ, BBH", "These 2 Companies Have No Competition", "Mid-Day Market Update: Crude Oil Down 3%; Proteon Therapeutics Shares Spike Higher", "Is This Why Acadia Pharmaceuticals Inc. Is Plunging Today?", "Analysts Forecast 12% Upside For BBH", "What's in the Cards for ACADIA (ACAD) this Earnings Season?", "Acadia Pharmaceuticals May Just Be the Best Long-Term Play on the Alzheimer's Disease Treatment Market", "Acadia Pharmaceuticals Becomes Oversold (ACAD)", "Implied IYH Analyst Target Price: $171", "Oversold Conditions For Acadia Pharmaceuticals (ACAD)", "Mid-Day Market Update: Crude Oil Down 3%; Proteon Therapeutics Shares Spike Higher", "Is This Why Acadia Pharmaceuticals Inc. Is Plunging Today?", "Analysts Forecast 12% Upside For BBH", "What's in the Cards for ACADIA (ACAD) this Earnings Season?", "Acadia Pharmaceuticals May Just Be the Best Long-Term Play on the Alzheimer's Disease Treatment Market", "Acadia Pharmaceuticals Becomes Oversold (ACAD)", "Implied IYH Analyst Target Price: $171", "Oversold Conditions For Acadia Pharmaceuticals (ACAD)", "Analysts Expect BBH Will Reach $134", "Earnings Reaction History: ACADIA Pharmaceuticals Inc, 50.0% Follow-Through Indicator, 5.9% Sensitive", "After-Hours Earnings Report for February 28, 2017 : CRM, ROST, PANW, UHS, TSRO, JAZZ, AR, DXCM, EPR, LOGM, ACAD, BUFF", "3 Earnings Reports That Should Be on Your Radar", "ACADIA Pharma (ACAD) Q4 Earnings: What's in Store this Time?", "First Week of April 21st Options Trading For Acadia Pharmaceuticals", "FBT, ACAD, ALNY, KITE: ETF Outflow Alert", "3 Top Biotech Stocks to Buy in 2017", "A Potential $20 Billion Indication? 2 Must-Have Biotechs Taking on Alzheimer's Disease", "Notable ETF Inflow Detected - XBI, CLVS, ACAD, UTHR", "Forget GW Pharmaceuticals -- These 2 Stocks Are Better Buys", "Forget Anavex Life Sciences Corp.: These 2 Biotech Stocks Are Better Buys", "3 Big Mergers & Acquisitions That We Could See in 2017", "How Risky Is Acadia Pharmaceuticals Stock?", "Acadia Pharmaceuticals (ACAD) Shares Cross Above 200 DMA", "Top Biotech Stocks to Buy in 2017", "Surprising Analyst 12-Month Target For FBT", "Why Acadia Pharmaceuticals Inc. Stock Slipped 19% in 2016", "Top Stocks to Buy in 2017", "3 Companies Whose Sales Could Double in 2017", "Acadia Pharmaceuticals' Alzheimer's Data Raises Some Questions", "4 Biotech Stocks to Buy in January", "3 Companies Whose Revenue Could Double in 2017", "Wednesday's ETF Movers: XBI, XLE", "Wall Street Sees Higher Open, Uncertainty Looms After Terror Attacks in Berlin, Zurich, Ankara", "Health Care Sector Update for 12/20/2016: BMY, ACAD, JNJ, PFE, ABT, MRK, AMGN", "Pre-Market Most Active for Dec 20, 2016 : AZN, ACAD, RAD, CNAT, ABB, BAC, GFI, MO, TVIX, BBRY, NVDA, XIV", "US Futures Point North, Uncertainty Looms After Terror Attacks in Berlin, Zurich, Ankara", "Why ACADIA Pharmaceuticals Inc. Is Soaring Today", "ACADIA Pharmaceuticals Inc.'s Stock Has Fallen 27% in 2016 -- Have We Hit Bottom?", "3 Beaten-Up Biotech Stocks: Are They Bargains?", "ACADIA Phase II Alzheimer's Drug Hits Primary Endpoint", "5 Biotech Stocks George Soros Is Buying", "Ready to Get In on Biotech? Check Out These 3 Stocks", "ACADIA Starts Phase II Schizophrenia Study on Pimavanserin", "ACAD Crosses Above Key Moving Average Level", "Why Acadia Pharmaceuticals Stock Is Surging Today", "Here's What Caused ACADIA Pharmaceuticals to Drop 27% in October", "Health Care Sector Update for 11/08/2016: ACAD,OSIR,BIOS", "3 Biotechs With Save-the-Date Catalysts on Tap", "Drug Stocks Earnings Roster for Nov 7: HZNP, ACAD & More", "What to Expect from Repros (RPRX) This Earnings Season", "Will Juno Therapeutics (JUNO) Disappoint in Q3 Earnings?", "What to Expect from Repros (RPRX) This Earnings Season", "Puma Biotechnology (PBYI) Q3 Earnings: What's in Store?", "ACADIA Pharma (ACAD): Will It Disappoint in Q3 Earnings?", "3 Charts That Show Why to Buy ACADIA Pharmaceuticals Stock", "Earnings Reaction History: ACADIA Pharmaceuticals Inc, 42.9% Follow-Through Indicator, 5.0% Sensitive", "Commit To Purchase Acadia Pharmaceuticals At $20, Earn 45.1% Annualized Using Options", "The Implied Analyst 12-Month Target For IWR", "These 2 Biotechs Could Vanish by 2018", "Acadia Pharmaceuticals Enters Oversold Territory (ACAD)", "Notable Two Hundred Day Moving Average Cross - ACAD", "10 Biotech Stocks to Put on Your Radar This Quarter", "3 Top Biotech Stocks to Buy in October", "Acadia Pharmaceuticals Becomes Oversold", "Why ACADIA Pharmaceuticals Tumbled 13.3% in August", "3 Stocks Begging for a Buyout", "3 Mid-Cap Healthcare Stocks You Can Buy Right Now", "Better Buy: ACADIA Pharmaceuticals Inc. vs. Sarepta Therapeutics Inc.", "3 Stocks That Could Make You Rich", "3 Stocks Up Over 1,000% in the Past 5 Years", "3 Biotech Stocks With Explosive Upside Potential", "A Critical Couple of Months for Acadia Pharmaceuticals", "Why ACADIA Pharmaceuticals Tumbled 13.3% in August", "3 Stocks Begging for a Buyout", "3 Mid-Cap Healthcare Stocks You Can Buy Right Now", "5 Drug Stocks to Watch for Earnings on Aug 4: BMRN & More", "ACADIA (ACAD) Q2 Earnings: What's in Store for the Stock?", "These 3 Biotechs Have Automatic Demand", "Wednesday's ETF Movers: XBI, GDXJ", "The 10 Best Small- and Mid-Cap Stocks to Buy Now", "This Could Be the Next Big Pharma Buyout", "3 Risky Biotech Stocks That Could Make You Rich", "Acadia Pharmaceuticals Inc.: Why ACAD Stock Will Be Volatile Over the Next Year", "These 3 Biotech Stocks Are Ridiculously Cheap Now", "ACADIA Pharmaceuticals Inc.'s Shareholders Are Having a Crazy Year. Here's Why", "Noteworthy ETF Inflows: XBI, ACAD, ANAC, MDVN", "Is Acadia Pharmaceuticals' Stock Still a Buy?", "Commit To Buy Acadia Pharmaceuticals At $18, Earn 11.4% Using Options", "This Could Be the Next Big Pharma Buyout", "Why Shares of ACADIA Pharmaceuticals Inc. Jumped Today", "Noteworthy Monday Option Activity: EAT, ACAD, LNKD", "How The Parts Add Up: IYY Headed For $115", "XBI, ACAD, MDVN, ANAC: Large Inflows Detected at ETF", "The 10 Best Healthcare Stocks to Buy Now", "Bullish Two Hundred Day Moving Average Cross - ACAD", "Acadia Pharmaceuticals Inc.: 7 Companies That Could Buy ACAD", "Notable ETF Inflow Detected - XBI, ACAD, ANAC, MDVN", "Why Shares of ACADIA Pharmaceuticals Inc. Jumped Today", "Noteworthy Monday Option Activity: EAT, ACAD, LNKD", "How The Parts Add Up: IYY Headed For $115", "XBI, ACAD, MDVN, ANAC: Large Inflows Detected at ETF", "VTI, VIS, ACAD, CPHD: Large Inflows Detected at ETF", "Notable ETF Outflow Detected - VTI, VIS, ACAD, CPHD", "SPDR S&P Biotech ETF Experiences Big Inflow", "3 Charts That Explain Acadia Pharmaceuticals Inc Stock", "3 Stocks the Smartest Investors Are Buying Now", "Why ACADIA Pharmaceuticals Inc Skyrocketed 46% Higher in March", "Here's Why Sarepta Therapeutics Jumped Today", "SPDR S&P Biotech ETF Experiences Big Outflow", "These 4 Healthcare Stocks Are All Soaring Today, and Here's Why", "3 Stocks That Could Double Your Money", "SPDR S&P Biotech ETF Experiences Big Inflow", "3 Charts That Explain Acadia Pharmaceuticals Inc Stock", "Mid-Day Market Update: ACADIA Pharmaceuticals Rises Following FDA Panel Vote; Verint Systems Shares Slide", "Why Acadia Pharmaceuticals' Stock Is Rocketing Higher Today", "US Stocks Eye Higher Open on Yellen Remarks; ADP Report Shows 200,000 Jobs Added in March", "Pre-Market Most Active for Mar 30, 2016 : STOR, ETE, FCAU, BAC, NOK, RIG, ACAD, TVIX, AAPL, YHOO, VOD, FB", "Why Lululemon Athletica, InterOil, and Acadia Pharmaceuticals Jumped Today", "This Could Be the Next Big Pharma Buyout", "Midday Update: Stocks Inching Higher After Mixed Data, Sliding Oil Price Encourages Caution", "Here's Why Acadia Pharmaceuticals' Stock Is Soaring Today", "Pre-Market Most Active for Mar 28, 2016 : ACAD, SPIL, TVIX, FCX, XIV, FB, BAC, VRX, YHOO, TWTR, PBR, CHK", "Why did Acadia Pharma (ACAD) Gained 17% on the Day?", "Mid-Afternoon Market Update: Dow Jumps 50 Points; Pandora Shares Slide", "Mid-Afternoon Market Update: US Stocks Gain; Markit Shares Surge", "Notable Friday Option Activity: AIRM, ACAD, SYK", "US Futures Continue Higher After Yellen Suggests Caution on Rate Increase", "Midday Update: Stocks Inching Higher After Mixed Data, Sliding Oil Price Encourages Caution", "Here's Why Acadia Pharmaceuticals' Stock Is Soaring Today", "Pre-Market Most Active for Mar 28, 2016 : ACAD, SPIL, TVIX, FCX, XIV, FB, BAC, VRX, YHOO, TWTR, PBR, CHK", "Why did Acadia Pharma (ACAD) Gained 17% on the Day?", "Baker Brothers Advisors buys ACADIA shares", "Commit To Purchase Acadia Pharmaceuticals At $18, Earn 18% Annualized Using Options", "Surprising Analyst 12-Month Target For IYH", "Interesting ACAD Put And Call Options For January 2018", "Health Care Sector Update for 11/02/2015: TTPH, ACAD, CTMX", "Why Acadia Pharmaceuticals Is Up Today", "Noteworthy Monday Option Activity: LPLA, ACAD, ECOM", "Oversold Conditions For Acadia Pharmaceuticals (ACAD)", "5 Sell-Ranked Biotechs That Fell More Than 5% Today", "3 Healthcare Stocks That Could Add a Spark to Your Portfolio", "Why Shares of ACADIA Pharmaceuticals Inc. Fell off a Cliff", "Interesting ACAD Put And Call Options For January 2018", "Why ACADIA Pharmaceuticals (ACAD) Could Be Positioned for a Slump", "3 Small-Cap Biopharma Stocks I'd Never Short", "Acadia Pharmaceuticals Becomes Oversold (ACAD)", "Why ACADIA Pharmaceuticals Inc. is Dropping Today", "Why ACADIA Pharmaceuticals Inc Jumped 17% in July", "The Zacks Analyst Blog Highlights: Amgen, Tetraphase, Geron, Alexion and ACADIA", "Why Parkinson's Disease-Focused ACADIA Pharmaceuticals is Soaring Today", "Acadia Pharmaceuticals (ACAD) Shares Cross Below 200 DMA", "Why ACADIA Pharmaceuticals (ACAD) Could Be Positioned for a Slump", "Pabrai Funds 2014 Investor Meeting Notes", "The Zacks Analyst Blog Highlights: Johnson & Johnson, AstraZeneca, ACADIA Pharmaceuticals, Actavis and Alkermes - Press Releases", "Acadia Pharmaceuticals Moves Up In Market Cap Rank, Passing QEP Resources", "3 Stocks That Could Double Your Money", "XLF, UBIO: Big ETF Inflows", "Should AbbVie, Inc. Buy Acadia Pharmaceuticals to Help Fight Parkinson's Disease?", "Healthcare Merger Monday: These 3 Stocks Could Be Healthcare's Next Buyout Targets", "1 Clinical-Stage Biotech Stock That Could Make You Into a Millionaire", "First Week of May 15th Options Trading For Acadia Pharmaceuticals (ACAD)", "The Zacks Analyst Blog Highlights: Amgen, Regeneron, Nektar, ACADIA and Pharmacyclics - Press Releases", "This Exciting Biotech Isn't Built to Last", "ACADIA Pharmaceuticals (ACAD) Crumbles: Stock Falls by 22.2% - Tale of the Tape", "Health Care Sector Update for 04/16/2015: ACAD, RCPT, HZNP", "Should AbbVie, Inc. Buy Acadia Pharmaceuticals to Help Fight Parkinson's Disease?", "US Futures Point Higher Amid Lower-Than-Expected Jobless Claims; Retail Sales Disappoint", "Correction: US Futures Higher Ahead of Weekly Jobless Claims Data, Retail Sales", "Pre-Market Most Active for Mar 12, 2015 : BAC, LL, ACAD, HSBC, EQM, CYBR, C, AAPL, QQQ, KO, AMRN, TVIX", "US Futures Mixed Ahead of Weekly Jobless Claims Data, Retail Sales", "After Hours Most Active for Mar 11, 2015 : SWKS, MSFT, MMS, FB, BAC, PETM, ACAD, HPQ, INTC, CRC, EVHC, HTZ", "Will Epizyme (EPZM) Miss Estimates This Earnings Season? - Analyst Blog", "ACADIA Down on Nuplazid NDA Delay and CEO Resignation - Analyst Blog", "Why Acadia Pharmaceuticals Inc. Stock Crashed", "US Futures Point Higher Amid Lower-Than-Expected Jobless Claims; Retail Sales Disappoint", "Correction: US Futures Higher Ahead of Weekly Jobless Claims Data, Retail Sales", "Will DexCom (DXCM) Loss Better Estimates this Earnings? - Analyst Blog", "Will Wright Medical (WMGI) Disappoint Earnings Again in Q4? - Analyst Blog", "Can Greatbatch (GB) Keep the Earnings Streak Alive in Q4? - Analyst Blog", "Ecolab's (ECL) Q4 Earnings: Will it Disappoint Estimates? - Analyst Blog", "Is a Surprise Coming for ACADIA Pharmaceuticals (ACAD) This Earnings Season? - Tale of the Tape", "Will Allscripts (MDRX) Surprise Earnings Estimates in Q4? - Analyst Blog", "Merrimack Pharmaceuticals (MACK): A Miss this Earnings? - Analyst Blog", "Will Aegerion (AEGR) Miss Earnings Estimates This Season? - Analyst Blog", "Will DexCom (DXCM) Loss Better Estimates this Earnings? - Analyst Blog", "Will Wright Medical (WMGI) Disappoint Earnings Again in Q4? - Analyst Blog", "Qiagen (QGEN) Disappoints with Q4 Earnings, Revenue Miss - Analyst Blog", "Can the Uptrend Continue for ACADIA Pharmaceuticals (ACAD)? - Tale of the Tape", "After-Hours Earnings Report for November 10, 2014 : RAX, DEI, WWD, PRAA, NPSP, CIB, ACAD, ATW, ATLS, CZR, HK, ARP", "First Week of June 2015 Options Trading For Acadia Pharmaceuticals (ACAD)", "3 Stocks I'll Buy if the Market Crashes", "ACAD Makes Bullish Cross Above Critical Moving Average", "Friday's ETF Movers: FNX, XBI", "ImmunoCellular Plans To Move ICT-107 Forward Into Phase III Trials Based On New Sub-Group Analysis Presented At ASCO", "Notable Two Hundred Day Moving Average Cross - ACAD", "First Week of September 18th Options Trading For Acadia Pharmaceuticals (ACAD)", "Friday's ETF Movers: XBI, GDXJ", "Upside in biotech, cloud, materials?", "Sector Update: Biotech Stocks Looking Strong As NASDAQ Struggles", "Sector Update: Biotechs Up Almost 1%, Adding To NASDAQ's Gain", "Sector Update: Biotech Stocks Getting Injection of Buying Interest", "Bulls think Acadia will keep running", "Market Wrap for Monday, June 10: Stocks Little Changed in Quiet Trade", "ACADIA Pharmaceuticals (ACAD) Jumps: Stock Rises 17.3% - Tale of the Tape", "Friday's ETF Movers: XBI, GDXJ", "Upside in biotech, cloud, materials?", "Sector Update: Biotech Stocks Looking Strong As NASDAQ Struggles", "Pre-Market Most Active for May 15, 2013 : AINV, BAC, SPWR, SIRI, CVRR, BBRY, NOK, AMTD, SNE, RH, ACAD, TSLA", "Benzinga Market Primer: Tuesday, May 7", "What's behind call activity in Acadia", "Weekly CFO Sells Highlight: KO, KKD, PIR, NPSP, ACAD", "An Insider Buys Shares of Mining Company Freeport-McMoRan While Graphic Packaging Sees a Sale", "Mid-Morning Market Update: Markets Continue to March Upwards, PC Makers Get Blasted", "Pre-Market Most Active for Apr 11, 2013 : PCS, RAD, SGYP, INFI, MSFT, ACAD, RLGY, QQQ, FTNT, NOK, BAC, HPQ", "Market Wrap for Thursday, April 11: Stock Market Rally Continues", "Mid-Afternoon Market Update: Rite Aid Posts Massive Rally, While Hewlett-Packard Takes a Hit", "Mid-Day Market Update: ACADIA Posts Massive Rally as AMD Falls", "Mid-Morning Market Update: Markets Tumble, Oracle Posts Downbeat Results", "Pre-Market Most Active for Mar 21, 2013 : NOK, ORCL, SNY, BAC, BBRY, TOT, ACAD, CWT, CSCO, AWC, QQQ, ZNGA", "Mid-Morning Market Update: Markets Plummet on Bad Data, Rite Aid Continues to Rally", "Mid-Afternoon Market Update: Markets Remain in the Red, DryShips Posts Strong Rally", "Mid-Day Market Update: Herman Miller Surges On Upbeat Earnings, Scholastic Falls", "Benzinga Market Primer: Tuesday, March 12", "After-Hours Earnings Report for March 12, 2013 : KW, DOLE, ACAD, GCA, GNMK, AVID, WSR, KTOS, GERN, ACRX, FOLD, GCAP", "Pre-Market Most Active for Nov 27, 2012 : ACAD, RAH, BAC, FB, NOK, SNE, GLW, SID, QQQ, AAPL, EBAY, ZNGA", "After Hours Most Active for Nov 27, 2012 : ACAD, GMCR, CIG, DISH, EFII, NOK, T, BAC, JEF, MSFT, DTV, HAL", "Zacks #1 Rank Additions for Wednesday - Tale of the Tape", "Market Wrap for Thursday, March 21: Stocks Give Back Wednesday's Gains", "Zacks #1 Rank Additions for Thursday - Tale of the Tape", "Zacks #1 Rank Additions for Tuesday - Tale of the Tape", "Zacks #1 Rank Additions for Friday - Tale of the Tape", "7 Biotech Penny Stocks to Buy", "Zacks #1 Rank Additions for Monday - Tale of the Tape"], "Elapsed Time": ["2 DAYS AGO", "JUN 17, 2020", "JUN 4, 2020", "JUN 2, 2020", "MAY 29, 2020", "MAY 28, 2020", "MAY 21, 2020", "MAY 20, 2020", "2 DAYS AGO", "MAY 9, 2020", "MAY 8, 2020", "APR 28, 2020", "MAR 31, 2020", "MAR 13, 2020", "MAR 12, 2020", "MAR 11, 2020", "MAY 19, 2020", "MAR 3, 2020", "FEB 27, 2020", "FEB 25, 2020", "FEB 13, 2020", "JAN 30, 2020", "JAN 23, 2020", "JAN 21, 2020", "MAR 6, 2020", "MAR 3, 2020", "JAN 9, 2020", "JAN 7, 2020", "JAN 7, 2020", "DEC 24, 2019", "DEC 23, 2019", "JAN 17, 2020", "DEC 6, 2019", "DEC 5, 2019", "DEC 5, 2019", "DEC 4, 2019", "DEC 2, 2019", "DEC 1, 2019", "NOV 27, 2019", "DEC 12, 2019", "NOV 8, 2019", "OCT 31, 2019", "OCT 31, 2019", "OCT 31, 2019", "OCT 4, 2019", "OCT 4, 2019", "SEP 26, 2019", "NOV 20, 2019", "SEP 23, 2019", "SEP 17, 2019", "SEP 17, 2019", "SEP 15, 2019", "SEP 11, 2019", "SEP 10, 2019", "SEP 9, 2019", "SEP 26, 2019", "SEP 23, 2019", "SEP 9, 2019", "SEP 9, 2019", "SEP 6, 2019", "SEP 6, 2019", "SEP 5, 2019", "SEP 9, 2019", "AUG 26, 2019", "AUG 22, 2019", "AUG 19, 2019", "AUG 1, 2019", "AUG 1, 2019", "AUG 1, 2019", "AUG 1, 2019", "SEP 3, 2019", "JUL 23, 2019", "JUL 23, 2019", "JUL 23, 2019", "JUL 23, 2019", "JUL 15, 2019", "JUL 3, 2019", "JUN 3, 2019", "AUG 1, 2019", "JUL 23, 2019", "MAY 2, 2019", "MAY 2, 2019", "APR 10, 2019", "MAR 26, 2019", "MAR 5, 2019", "MAY 23, 2019", "FEB 27, 2019", "FEB 27, 2019", "FEB 26, 2019", "FEB 15, 2019", "FEB 14, 2019", "FEB 11, 2019", "FEB 11, 2019", "FEB 28, 2019", "FEB 7, 2019", "JAN 31, 2019", "JAN 30, 2019", "JAN 28, 2019", "JAN 24, 2019", "JAN 17, 2019", "JAN 11, 2019", "FEB 8, 2019", "JAN 8, 2019", "DEC 20, 2018", "DEC 17, 2018", "NOV 29, 2018", "NOV 28, 2018", "NOV 27, 2018", "NOV 27, 2018", "JAN 10, 2019", "NOV 27, 2018", "NOV 27, 2018", "NOV 16, 2018", "NOV 8, 2018", "NOV 6, 2018", "NOV 6, 2018", "NOV 1, 2018", "NOV 27, 2018", "OCT 30, 2018", "OCT 10, 2018", "OCT 4, 2018", "OCT 2, 2018", "OCT 1, 2018", "SEP 27, 2018", "SEP 26, 2018", "OCT 31, 2018", "SEP 22, 2018", "SEP 21, 2018", "SEP 20, 2018", "SEP 14, 2018", "SEP 10, 2018", "SEP 10, 2018", "AUG 16, 2018", "SEP 25, 2018", "AUG 9, 2018", "AUG 8, 2018", "JUL 31, 2018", "JUL 13, 2018", "JUL 13, 2018", "JUL 12, 2018", "JUL 12, 2018", "AUG 9, 2018", "AUG 9, 2018", "AUG 8, 2018", "JUL 31, 2018", "JUL 13, 2018", "MAY 18, 2018", "MAY 10, 2018", "JUL 9, 2018", "JUL 8, 2018", "JUN 29, 2018", "JUN 14, 2018", "JUN 7, 2018", "MAY 23, 2018", "MAY 18, 2018", "MAY 10, 2018", "JUL 9, 2018", "MAY 4, 2018", "MAY 4, 2018", "MAY 4, 2018", "MAY 4, 2018", "MAY 4, 2018", "MAY 1, 2018", "APR 27, 2018", "MAY 7, 2018", "APR 9, 2018", "APR 3, 2018", "MAR 29, 2018", "MAR 20, 2018", "MAR 12, 2018", "MAR 8, 2018", "FEB 28, 2018", "APR 9, 2018", "APR 9, 2018", "APR 3, 2018", "MAR 29, 2018", "FEB 20, 2018", "FEB 14, 2018", "FEB 8, 2018", "FEB 6, 2018", "FEB 28, 2018", "FEB 27, 2018", "FEB 22, 2018", "FEB 20, 2018", "FEB 20, 2018", "DEC 29, 2017", "DEC 28, 2017", "FEB 1, 2018", "DEC 26, 2017", "DEC 20, 2017", "DEC 20, 2017", "DEC 20, 2017", "DEC 14, 2017", "DEC 13, 2017", "DEC 13, 2017", "DEC 27, 2017", "DEC 26, 2017", "DEC 20, 2017", "DEC 20, 2017", "DEC 20, 2017", "NOV 22, 2017", "NOV 20, 2017", "NOV 11, 2017", "DEC 11, 2017", "DEC 8, 2017", "DEC 4, 2017", "NOV 30, 2017", "NOV 27, 2017", "NOV 3, 2017", "NOV 3, 2017", "NOV 3, 2017", "NOV 8, 2017", "NOV 8, 2017", "NOV 7, 2017", "NOV 7, 2017", "NOV 6, 2017", "OCT 31, 2017", "OCT 31, 2017", "NOV 2, 2017", "OCT 30, 2017", "OCT 30, 2017", "OCT 19, 2017", "OCT 13, 2017", "OCT 12, 2017", "OCT 11, 2017", "OCT 10, 2017", "OCT 30, 2017", "OCT 30, 2017", "OCT 30, 2017", "OCT 9, 2017", "OCT 5, 2017", "OCT 5, 2017", "OCT 5, 2017", "OCT 5, 2017", "OCT 10, 2017", "OCT 4, 2017", "OCT 4, 2017", "OCT 4, 2017", "SEP 29, 2017", "SEP 26, 2017", "SEP 21, 2017", "SEP 21, 2017", "OCT 4, 2017", "SEP 19, 2017", "SEP 19, 2017", "SEP 18, 2017", "SEP 15, 2017", "SEP 14, 2017", "SEP 14, 2017", "SEP 13, 2017", "SEP 21, 2017", "SEP 19, 2017", "SEP 19, 2017", "SEP 18, 2017", "SEP 15, 2017", "SEP 14, 2017", "SEP 14, 2017", "AUG 29, 2017", "SEP 12, 2017", "AUG 28, 2017", "AUG 28, 2017", "AUG 27, 2017", "AUG 25, 2017", "AUG 25, 2017", "AUG 24, 2017", "AUG 23, 2017", "AUG 29, 2017", "AUG 28, 2017", "AUG 28, 2017", "AUG 14, 2017", "AUG 14, 2017", "AUG 9, 2017", "AUG 7, 2017", "AUG 2, 2017", "AUG 18, 2017", "JUL 12, 2017", "JUN 26, 2017", "JUN 23, 2017", "JUN 19, 2017", "JUN 16, 2017", "JUN 6, 2017", "MAY 10, 2017", "JUL 18, 2017", "MAY 10, 2017", "MAY 10, 2017", "MAY 4, 2017", "MAY 2, 2017", "APR 25, 2017", "APR 5, 2017", "APR 3, 2017", "MAY 10, 2017", "MAY 10, 2017", "MAY 10, 2017", "MAY 4, 2017", "MAY 2, 2017", "APR 25, 2017", "APR 5, 2017", "APR 3, 2017", "MAY 10, 2017", "MAR 2, 2017", "FEB 28, 2017", "FEB 28, 2017", "FEB 24, 2017", "FEB 23, 2017", "FEB 22, 2017", "FEB 21, 2017", "MAR 26, 2017", "FEB 11, 2017", "FEB 2, 2017", "FEB 2, 2017", "FEB 1, 2017", "FEB 1, 2017", "JAN 30, 2017", "JAN 26, 2017", "JAN 22, 2017", "JAN 19, 2017", "JAN 13, 2017", "JAN 7, 2017", "JAN 7, 2017", "JAN 4, 2017", "DEC 26, 2016", "DEC 23, 2016", "JAN 4, 2017", "DEC 20, 2016", "DEC 20, 2016", "DEC 20, 2016", "DEC 20, 2016", "DEC 20, 2016", "DEC 19, 2016", "DEC 9, 2016", "DEC 21, 2016", "NOV 22, 2016", "NOV 20, 2016", "NOV 16, 2016", "NOV 10, 2016", "NOV 8, 2016", "NOV 8, 2016", "NOV 8, 2016", "NOV 29, 2016", "NOV 4, 2016", "NOV 4, 2016", "NOV 3, 2016", "NOV 3, 2016", "NOV 3, 2016", "OCT 31, 2016", "OCT 28, 2016", "NOV 7, 2016", "OCT 19, 2016", "OCT 10, 2016", "OCT 6, 2016", "OCT 5, 2016", "OCT 4, 2016", "OCT 3, 2016", "OCT 2, 2016", "OCT 27, 2016", "SEP 11, 2016", "SEP 11, 2016", "SEP 10, 2016", "SEP 3, 2016", "AUG 31, 2016", "AUG 28, 2016", "AUG 23, 2016", "SEP 22, 2016", "SEP 11, 2016", "SEP 11, 2016", "SEP 10, 2016", "AUG 3, 2016", "AUG 2, 2016", "JUL 23, 2016", "JUL 20, 2016", "AUG 19, 2016", "JUL 18, 2016", "JUL 12, 2016", "JUL 5, 2016", "JUL 5, 2016", "JUN 28, 2016", "JUN 15, 2016", "JUN 12, 2016", "JUL 19, 2016", "JUL 18, 2016", "JUN 6, 2016", "JUN 6, 2016", "MAY 31, 2016", "MAY 26, 2016", "MAY 24, 2016", "MAY 17, 2016", "JUN 8, 2016", "JUN 6, 2016", "JUN 6, 2016", "JUN 6, 2016", "MAY 31, 2016", "MAY 26, 2016", "APR 21, 2016", "MAY 11, 2016", "APR 13, 2016", "APR 10, 2016", "APR 9, 2016", "APR 8, 2016", "APR 6, 2016", "APR 5, 2016", "APR 4, 2016", "APR 18, 2016", "APR 13, 2016", "MAR 30, 2016", "MAR 30, 2016", "MAR 30, 2016", "MAR 30, 2016", "MAR 30, 2016", "MAR 30, 2016", "APR 3, 2016", "MAR 28, 2016", "MAR 28, 2016", "MAR 28, 2016", "MAR 28, 2016", "MAR 28, 2016", "MAR 21, 2016", "MAR 18, 2016", "MAR 30, 2016", "MAR 28, 2016", "MAR 28, 2016", "MAR 28, 2016", "MAR 28, 2016", "JAN 12, 2016", "JAN 11, 2016", "MAR 7, 2016", "NOV 16, 2015", "NOV 2, 2015", "NOV 2, 2015", "NOV 2, 2015", "SEP 28, 2015", "SEP 25, 2015", "SEP 16, 2015", "JAN 7, 2016", "NOV 16, 2015", "AUG 14, 2015", "AUG 12, 2015", "AUG 7, 2015", "AUG 7, 2015", "AUG 5, 2015", "SEP 10, 2015", "SEP 3, 2015", "AUG 20, 2015", "AUG 14, 2015", "JUN 30, 2015", "MAY 26, 2015", "MAY 11, 2015", "APR 19, 2015", "JUL 24, 2015", "APR 8, 2015", "MAR 30, 2015", "MAR 29, 2015", "MAR 27, 2015", "MAR 19, 2015", "MAR 19, 2015", "MAR 13, 2015", "APR 16, 2015", "APR 8, 2015", "MAR 12, 2015", "MAR 12, 2015", "MAR 12, 2015", "MAR 12, 2015", "MAR 11, 2015", "FEB 25, 2015", "MAR 13, 2015", "MAR 12, 2015", "MAR 12, 2015", "FEB 24, 2015", "FEB 23, 2015", "FEB 23, 2015", "FEB 20, 2015", "FEB 20, 2015", "FEB 25, 2015", "FEB 24, 2015", "FEB 24, 2015", "FEB 24, 2015", "FEB 23, 2015", "FEB 23, 2015", "JAN 30, 2015", "FEB 19, 2015", "NOV 10, 2014", "OCT 23, 2014", "OCT 20, 2014", "JUL 1, 2014", "JUN 27, 2014", "JUN 2, 2014", "MAR 25, 2014", "JAN 23, 2015", "FEB 21, 2014", "JAN 20, 2014", "DEC 2, 2013", "NOV 26, 2013", "NOV 20, 2013", "JUN 17, 2013", "JUN 10, 2013", "FEB 24, 2014", "FEB 21, 2014", "JAN 20, 2014", "MAY 20, 2013", "MAY 15, 2013", "MAY 7, 2013", "APR 18, 2013", "APR 16, 2013", "JUN 6, 2013", "APR 11, 2013", "APR 11, 2013", "APR 11, 2013", "APR 11, 2013", "APR 11, 2013", "MAR 21, 2013", "MAR 21, 2013", "APR 12, 2013", "MAR 21, 2013", "MAR 21, 2013", "MAR 12, 2013", "MAR 12, 2013", "NOV 27, 2012", "NOV 27, 2012", "JAN 25, 2012", "MAR 21, 2013", "JAN 19, 2012", "JAN 17, 2012", "JAN 13, 2012", "JUN 29, 2011", "JAN 23, 2012"], "Published Date": [], "Link": ["https://www.nasdaq.com/articles/2-biotech-stocks-with-major-incoming-catalysts-2020-06-24", "https://www.nasdaq.com/articles/3-strong-buy-healthcare-stocks-that-should-remain-healthy-2020-06-17", "https://www.nasdaq.com/articles/interesting-acad-put-and-call-options-for-july-24th-2020-06-04", "https://www.nasdaq.com/articles/is-acadia-pharmaceuticals-a-buy-2020-06-02", "https://www.nasdaq.com/articles/nows-the-time-to-buy-these-3-stocks-2020-05-29", "https://www.nasdaq.com/articles/acad-july-10th-options-begin-trading-2020-05-28", "https://www.nasdaq.com/articles/interesting-acad-put-and-call-options-for-july-2nd-2020-05-21", "https://www.nasdaq.com/articles/analysts-predict-11-gains-ahead-for-the-holdings-of-iyh-2020-05-20", "https://www.nasdaq.com/articles/2-biotech-stocks-with-major-incoming-catalysts-2020-06-24", "https://www.nasdaq.com/articles/is-axsome-therapeutics-a-screaming-buy-2020-05-09", "https://www.nasdaq.com/articles/acadia-pharmaceuticals-acad-q1-2020-earnings-call-transcript-2020-05-09", "https://www.nasdaq.com/articles/10-stocks-to-buy-for-an-aging-population-2020-04-28", "https://www.nasdaq.com/articles/implied-rxl-analyst-target-price%3A-%24112-2020-03-31", "https://www.nasdaq.com/articles/interesting-acad-put-and-call-options-for-may-1st-2020-03-13", "https://www.nasdaq.com/articles/this-1-stock-is-a-good-buy-during-the-coronavirus-sell-off-2020-03-12", "https://www.nasdaq.com/articles/acadia-pharmaceuticals-breaks-below-200-day-moving-average-notable-for-acad-2020-03-11", "https://www.nasdaq.com/articles/is-amarin-stock-a-buy-2020-05-19", "https://www.nasdaq.com/articles/first-week-of-april-9th-options-trading-for-acadia-pharmaceuticals-acad-2020-03-03", "https://www.nasdaq.com/articles/acadia-pharmaceuticals-acad-q4-2019-earnings-call-transcript-2020-02-27", "https://www.nasdaq.com/articles/notable-tuesday-option-activity%3A-acad-knx-expe-2020-02-25", "https://www.nasdaq.com/articles/noteworthy-thursday-option-activity%3A-avgo-acad-gddy-2020-02-13", "https://www.nasdaq.com/articles/3-top-biotech-stocks-to-buy-right-now-2020-01-30", "https://www.nasdaq.com/articles/interesting-acad-put-and-call-options-for-march-6th-2020-01-23", "https://www.nasdaq.com/articles/add-up-the-parts%3A-fbt-could-be-worth-%24182-2020-01-21", "https://www.nasdaq.com/articles/6-quality-biotech-stocks-on-sale-now-2020-03-06", "https://www.nasdaq.com/articles/first-week-of-april-9th-options-trading-for-acadia-pharmaceuticals-acad-2020-03-03", "https://www.nasdaq.com/articles/acad-february-28th-options-begin-trading-2020-01-09", "https://www.nasdaq.com/articles/the-10-best-healthcare-stocks-of-the-decade-2020-01-07", "https://www.nasdaq.com/articles/where-will-gw-pharmaceuticals-be-in-5-years-2020-01-07", "https://www.nasdaq.com/articles/2-biotech-stocks-poised-to-soar-in-2020-2019-12-24", "https://www.nasdaq.com/articles/3-stocks-that-could-be-the-next-biotech-buyouts-2019-12-23", "https://www.nasdaq.com/articles/acadia-pharmaceuticals-larger-than-sp-500-component-flowserve-corp-2020-01-17", "https://www.nasdaq.com/articles/save-yourself-the-migraine-and-buy-this-1-pharma-stock-now-2019-12-06", "https://www.nasdaq.com/articles/health-care-sector-update-for-12-05-2019%3A-auph-acad-sage-jnj-pfe-abt-mrk-amgn-2019-12-05", "https://www.nasdaq.com/articles/why-acadia-pharmaceuticals-stock-is-on-fire-today-2019-12-05", "https://www.nasdaq.com/articles/auph-soars-on-lupus-trial-results-acad-on-watch-alna-trims-workforce-2019-12-04", "https://www.nasdaq.com/articles/7-exciting-biotech-stocks-to-buy-now-2019-12-02", "https://www.nasdaq.com/articles/3-monster-growth-stocks-that-are-still-in-the-buy-zone-2019-12-01", "https://www.nasdaq.com/articles/interesting-acad-put-and-call-options-for-january-2020-2019-11-27", "https://www.nasdaq.com/articles/analysts-expect-fbt-will-reach-%24179-2019-12-12", "https://www.nasdaq.com/articles/iyhs-holdings-imply-12-gain-potential-2019-11-08", "https://www.nasdaq.com/articles/is-acadia-pharmaceuticals-stock-now-a-buy-2019-10-31", "https://www.nasdaq.com/articles/acadia-pharmaceuticals-delivers-record-q3-revenue-fueled-by-antipsychotic-drug-nuplazid", "https://www.nasdaq.com/articles/acadia-pharmaceuticals-acad-q3-2019-earnings-call-transcript-2019-10-31", "https://www.nasdaq.com/articles/3-mid-cap-biotech-stocks-to-consider-buying-now-2019-10-04", "https://www.nasdaq.com/articles/heres-why-acadia-pharmaceuticals-jumped-30.1-in-september-2019-10-04", "https://www.nasdaq.com/articles/november-8th-options-now-available-for-acadia-pharmaceuticals-acad-2019-09-26", "https://www.nasdaq.com/articles/notable-wednesday-option-activity%3A-acad-spwr-zs-2019-11-20", "https://www.nasdaq.com/articles/health-care-sector-update-for-09-23-2019%3A-acadakcapstvcmd-2019-09-23", "https://www.nasdaq.com/articles/how-doctors-treat-dementia-and-lung-cancer-could-be-about-to-change-2019-09-18", "https://www.nasdaq.com/articles/5-top-stock-trades-for-wednesday%3A-ba-acb-pins-2019-09-17", "https://www.nasdaq.com/articles/3-biotech-stocks-that-soared-last-week-2019-09-15", "https://www.nasdaq.com/articles/does-acadia-pharmaceuticals-have-more-room-to-run-2019-09-11", "https://www.nasdaq.com/articles/is-acadia-pharmaceuticals-a-good-biotech-stock-to-buy-now-2019-09-10", "https://www.nasdaq.com/articles/6-top-gainers-in-healthcare-sector-acad-ardx-kool...-2019-09-09", "https://www.nasdaq.com/articles/fbt-acad-uthr-nbix%3A-etf-outflow-alert-2019-09-26", "https://www.nasdaq.com/articles/health-care-sector-update-for-09-23-2019%3A-acadakcapstvcmd-2019-09-23", "https://www.nasdaq.com/articles/health-care-sector-update-for-09-09-2019%3A-achcacadrgen-2019-09-09", "https://www.nasdaq.com/articles/health-care-sector-update-for-09-09-2019%3A-acad-axnx-amgn-jnj-pfe-abt-mrk-2019-09-09", "https://www.nasdaq.com/articles/acadia-pharmaceuticals-acad-shares-cross-below-200-dma-2019-09-06", "https://www.nasdaq.com/articles/october-25th-options-now-available-for-acadia-pharmaceuticals-acad-2019-09-06", "https://www.nasdaq.com/articles/look-under-the-hood%3A-vb-has-16-upside-2019-09-05", "https://www.nasdaq.com/articles/why-acadia-pharmaceuticals-stock-skyrocketed-today-2019-09-09", "https://www.nasdaq.com/articles/acad-october-4th-options-begin-trading-2019-08-26", "https://www.nasdaq.com/articles/first-week-of-october-18th-options-trading-for-acadia-pharmaceuticals-acad-2019-08-22", "https://www.nasdaq.com/articles/first-week-of-march-2020-options-trading-for-acadia-pharmaceuticals-acad-2019-08-19", "https://www.nasdaq.com/articles/health-care-sector-update-for-08-01-2019%3A-syrsmygnacadabmd-2019-08-01", "https://www.nasdaq.com/articles/health-care-sector-update-for-08-01-2019%3A-mygnacadabmd-2019-08-01", "https://www.nasdaq.com/articles/why-acadia-pharmaceuticals-stock-is-crushing-it-today-2019-08-01", "https://www.nasdaq.com/articles/acadia-pharmaceuticals-beats-expectations-in-q2-2019-08-01", "https://www.nasdaq.com/articles/october-11th-options-now-available-for-acadia-pharmaceuticals-acad-2019-09-03", "https://www.nasdaq.com/articles/rsi-alert%3A-acadia-pharmaceuticals-acad-now-oversold-2019-07-23", "https://www.nasdaq.com/articles/acadia-pharmaceuticals-breaks-below-200-day-moving-average-notable-for-acad-2019-07-23", "https://www.nasdaq.com/articles/why-acadia-pharmaceuticals-is-tanking-today-2019-07-23", "https://www.nasdaq.com/articles/are-these-2-beaten-down-biotech-stocks-worth-buying-2019-07-23", "https://www.nasdaq.com/articles/interesting-acad-put-and-call-options-for-july-19th-2019-07-15", "https://www.nasdaq.com/articles/jkks-holdings-imply-14-gain-potential-2019-07-03", "https://www.nasdaq.com/articles/first-week-september-20th-options-trading-acadia-pharmaceuticals-acad-2019-06-03", "https://www.nasdaq.com/articles/acadia-pharmaceuticals-acad-q2-2019-earnings-call-transcript-2019-08-01", "https://www.nasdaq.com/articles/rsi-alert%3A-acadia-pharmaceuticals-acad-now-oversold-2019-07-23", "https://www.nasdaq.com/articles/june-14th-options-now-available-acadia-pharmaceuticals-acad-2019-05-02", "https://www.nasdaq.com/articles/acadia-pharmaceuticals-acad-q1-2019-earnings-call-transcript-2019-05-02", "https://www.nasdaq.com/articles/3-biotech-stocks-doubled-after-hitting-bottom-2018-2019-04-10", "https://www.nasdaq.com/articles/notable-etf-inflow-detected-fbt-ions-rare-acad-2019-03-26", "https://www.nasdaq.com/articles/why-acadia-pharmaceuticals-stock-perked-february-2019-03-05", "https://www.nasdaq.com/articles/interesting-acad-put-and-call-options-july-5th-2019-05-23", "https://www.nasdaq.com/articles/wednesdays-etf-movers-fbt-ihf-2019-02-27", "https://www.nasdaq.com/articles/acadia-pharmaceuticals-inc-acad-q4-2018-earnings-conference-call-transcript-2019-02-27", "https://www.nasdaq.com/articles/earnings-reaction-history-acadia-pharma-545-follow-through-indicator-85-sensitive-2019-02", "https://www.nasdaq.com/articles/whats-in-the-cards-for-bausch-health-bhc-q4-earnings-2019-02-15", "https://www.nasdaq.com/articles/5-drug-biotech-stocks-set-to-beat-estimates-in-q4-earnings-2019-02-14", "https://www.nasdaq.com/articles/zoetis-zts-to-report-q4-earnings%3A-whats-in-the-cards-2019-02-11", "https://www.nasdaq.com/articles/is-a-disappointment-in-store-for-incyte-incy-q4-earnings-2019-02-11", "https://www.nasdaq.com/articles/noteworthy-thursday-option-activity-fro-ulta-acad-2019-02-28", "https://www.nasdaq.com/articles/smartest-people-wall-street-are-buying-these-3-stocks-should-you-2019-02-07", "https://www.nasdaq.com/articles/will-gilead-gild-q4-earnings-disappoint-on-weak-hcv-sales-2019-01-31", "https://www.nasdaq.com/articles/is-a-beat-in-store-for-vertex-vrtx-this-earnings-season-2019-01-30", "https://www.nasdaq.com/articles/macrogenics-up-on-lifting-of-partial-hold-on-cancer-candidate-2019-01-28", "https://www.nasdaq.com/articles/will-acadia-pharmaceuticals-continue-to-surge-higher-2019-01-24", "https://www.nasdaq.com/articles/amgens-postmenopausal-osteoporosis-drug-gets-fda-panel-nod-2019-01-17", "https://www.nasdaq.com/articles/first-week-acad-march-1st-options-trading-2019-01-11", "https://www.nasdaq.com/articles/tilray-tlry-to-report-q4-earnings%3A-whats-in-the-cards-2019-02-08", "https://www.nasdaq.com/articles/heres-why-acadia-pharmaceuticals-dropped-152-december-2019-01-08", "https://www.nasdaq.com/articles/acadia-pharmaceuticals-becomes-oversold-acad-2018-12-20", "https://www.nasdaq.com/articles/acadia-pharmaceuticals-breaks-above-200-day-moving-average-bullish-acad-2018-12-17", "https://www.nasdaq.com/articles/acad-january-2019-options-begin-trading-2018-11-29", "https://www.nasdaq.com/articles/heres-why-acadia-pharmaceuticals-soaring-2018-11-28", "https://www.nasdaq.com/articles/xbi-acad-tsro-ions-etf-outflow-alert-2018-11-27", "https://www.nasdaq.com/articles/health-care-sector-update-11272018-halogthxacad-2018-11-27", "https://www.nasdaq.com/articles/thursdays-etf-movers-fbt-gdxj-2019-01-10", "https://www.nasdaq.com/articles/why-acadia-pharmaceuticals-plummeting-2018-11-27", "https://www.nasdaq.com/articles/health-care-sector-update-11272018-vrtxhalogthxacad-2018-11-27", "https://www.nasdaq.com/articles/noteworthy-etf-outflows-xbi-acad-ions-arry-2018-11-16", "https://www.nasdaq.com/articles/december-28th-options-now-available-acadia-pharmaceuticals-acad-2018-11-08", "https://www.nasdaq.com/articles/acadia-pharmaceuticals-acad-reports-q3-loss-tops-revenue-estimates-2018-11-06", "https://www.nasdaq.com/articles/earnings-reaction-history-acadia-pharmaceuticals-inc-600-follow-through-indicator-85", "https://www.nasdaq.com/articles/noteworthy-etf-inflows-xbi-acad-arry-vktx-2018-11-01", "https://www.nasdaq.com/articles/health-care-sector-update-11272018-dvavrtxacadgthx-2018-11-27", "https://www.nasdaq.com/articles/earnings-preview%3A-acadia-pharmaceuticals-acad-q3-earnings-expected-to-decline-2018-10-30", "https://www.nasdaq.com/articles/heres-why-acadia-pharmaceuticals-jumped-46-september-2018-10-10", "https://www.nasdaq.com/articles/noteworthy-thursday-option-activity-acad-cl-ingn-2018-10-04", "https://www.nasdaq.com/articles/5-top-healthcare-mutual-funds-to-buy-in-october-2018-10-02", "https://www.nasdaq.com/articles/5-best-biotech-stocks-to-buy-in-october-2018-10-01", "https://www.nasdaq.com/articles/interesting-acad-put-and-call-options-november-9th-2018-09-27", "https://www.nasdaq.com/articles/biotech-stock-roundup%3A-alxn-soliris-successful-respite-for-sarepta-amrn-soars-2018-09-26", "https://www.nasdaq.com/articles/acad-makes-notable-cross-below-critical-moving-average-2018-10-31", "https://www.nasdaq.com/articles/3-biotech-stocks-soared-week-are-they-buys-2018-09-22", "https://www.nasdaq.com/articles/fda-confirms-positive-safety-profile-of-acadias-nuplazid-2018-09-21", "https://www.nasdaq.com/articles/heres-why-acadia-pharmaceuticals-inc-spiked-over-26-today-2018-09-20", "https://www.nasdaq.com/articles/noteworthy-friday-option-activity-fdx-wynn-acad-2018-09-14", "https://www.nasdaq.com/articles/health-care-sector-update-09102018-acadmrkfold-2018-09-10", "https://www.nasdaq.com/articles/health-care-sector-update-09102018-myok-acad-mrk-fold-lly-2018-09-10", "https://www.nasdaq.com/articles/better-speculative-biotech-stock-amarin-corporation-vs-geron-corporation-2018-08-16", "https://www.nasdaq.com/articles/bullish-two-hundred-day-moving-average-cross-acad-2018-09-25", "https://www.nasdaq.com/articles/after-hours-most-active-aug-9-2018-abev-qqq-ver-brkb-f-dbx-kmi-wfc-acad-grpn-ea-ostk-2018", "https://www.nasdaq.com/articles/acadia-pharmaceuticals-acad-reports-q2-loss-lags-revenue-estimates-2018-08-08", "https://www.nasdaq.com/articles/will-acadia-acad-disappoint-investors-in-q2-earnings-2018-07-31", "https://www.nasdaq.com/articles/5-big-pharma-stocks-investors-love-right-now-2018-07-13", "https://www.nasdaq.com/articles/better-buy-acadia-pharmaceuticals-vs-eli-lilly-2018-07-13", "https://www.nasdaq.com/articles/dopamine-and-weather-part-2-2018-07-12", "https://www.nasdaq.com/articles/acad-august-31st-options-begin-trading-2018-07-12", "https://www.nasdaq.com/articles/why-acadia-pharmaceuticals-stock-tanking-today-2018-08-09", "https://www.nasdaq.com/articles/after-hours-most-active-aug-9-2018-abev-qqq-ver-brkb-f-dbx-kmi-wfc-acad-grpn-ea-ostk-2018", "https://www.nasdaq.com/articles/acadia-pharmaceuticals-acad-reports-q2-loss-lags-revenue-estimates-2018-08-08", "https://www.nasdaq.com/articles/will-acadia-acad-disappoint-investors-in-q2-earnings-2018-07-31", "https://www.nasdaq.com/articles/5-big-pharma-stocks-investors-love-right-now-2018-07-13", "https://www.nasdaq.com/articles/better-buy-acadia-pharmaceuticals-vs-biogen-2018-05-18", "https://www.nasdaq.com/articles/interesting-acad-put-and-call-options-june-29th-2018-05-10", "https://www.nasdaq.com/articles/why-acadia-pharmaceuticals-stock-falling-today-2018-07-09", "https://www.nasdaq.com/articles/3-worst-biotech-stocks-2018-so-far-2018-07-08", "https://www.nasdaq.com/articles/why-acadia-pharmaceuticals-soaring-today-2018-06-29", "https://www.nasdaq.com/articles/noteworthy-thursday-option-activity-acad-etsy-insy-2018-06-14", "https://www.nasdaq.com/articles/july-27th-options-now-available-acadia-pharmaceuticals-acad-2018-06-07", "https://www.nasdaq.com/articles/acadia-pharmaceuticals-acad-buy-2018-05-23", "https://www.nasdaq.com/articles/better-buy-acadia-pharmaceuticals-vs-biogen-2018-05-18", "https://www.nasdaq.com/articles/interesting-acad-put-and-call-options-june-29th-2018-05-10", "https://www.nasdaq.com/articles/why-acadia-pharmaceuticals-stock-falling-today-2018-07-09", "https://www.nasdaq.com/articles/acadia-posts-narrower-than-expected-loss-in-q1-sales-beat-2018-05-04", "https://www.nasdaq.com/articles/earnings-reaction-history-acadia-pharmaceuticals-inc-667-follow-through-indicator-92", "https://www.nasdaq.com/articles/why-acadia-pharmaceuticals-jumped-11-higher-today-2018-05-04", "https://www.nasdaq.com/articles/health-care-sector-update-05042018-srpt-acad-ptla-celg-2018-05-04", "https://www.nasdaq.com/articles/health-care-sector-update-05042018-acadptlacelg-2018-05-04", "https://www.nasdaq.com/articles/will-acadia-acad-disappoint-investors-this-earnings-season-2018-05-01", "https://www.nasdaq.com/articles/health-care-sector-update-04272018-acadgildhrcsny-2018-04-27", "https://www.nasdaq.com/articles/are-these-2-biotech-laggards-ready-rebound-2018-05-07", "https://www.nasdaq.com/articles/mid-afternoon-market-update-crude-oil-over-2-therapix-biosciences-shares-spike-higher-0", "https://www.nasdaq.com/articles/better-buy-acadia-pharmaceuticals-vs-eli-lilly-2018-04-03", "https://www.nasdaq.com/articles/acad-may-11th-options-begin-trading-2018-03-29", "https://www.nasdaq.com/articles/acadia-pharmaceuticals-buy-2018-03-20", "https://www.nasdaq.com/articles/acadia-pharmaceuticals-stock-now-strong-buy-2018-03-12", "https://www.nasdaq.com/articles/interesting-acad-put-and-call-options-april-27th-2018-03-08", "https://www.nasdaq.com/articles/why-acadia-pharmaceuticals-stock-crashing-today-2018-02-28", "https://www.nasdaq.com/articles/mid-afternoon-market-update-crude-oil-over-2-therapix-biosciences-shares-spike-higher-2018", "https://www.nasdaq.com/articles/mid-afternoon-market-update-crude-oil-over-2-therapix-biosciences-shares-spike-higher-0", "https://www.nasdaq.com/articles/better-buy-acadia-pharmaceuticals-vs-eli-lilly-2018-04-03", "https://www.nasdaq.com/articles/acad-may-11th-options-begin-trading-2018-03-29", "https://www.nasdaq.com/articles/will-acadia-acad-disappoint-investors-in-q4-earnings-2018-02-20", "https://www.nasdaq.com/articles/interesting-acad-put-and-call-options-april-20th-2018-02-14", "https://www.nasdaq.com/articles/interesting-acad-put-and-call-options-march-29th-2018-02-08", "https://www.nasdaq.com/articles/noteworthy-tuesday-option-activity-tsla-hd-acad-2018-02-06", "https://www.nasdaq.com/articles/mid-morning-market-update-markets-open-higher-lowes-profit-misses-views-2018-02-28", "https://www.nasdaq.com/articles/earnings-reaction-history-acadia-pharmaceuticals-inc-625-follow-through-indicator-83", "https://www.nasdaq.com/articles/interesting-acad-put-and-call-options-april-6th-2018-02-22", "https://www.nasdaq.com/articles/george-soros-just-dumped-these-2-healthcare-stocks-should-you-2018-02-20", "https://www.nasdaq.com/articles/will-acadia-acad-disappoint-investors-in-q4-earnings-2018-02-20", "https://www.nasdaq.com/articles/therapeuticsmd-submits-nda-for-vms-candidate-shares-rise-2017-12-29", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-acadia-pharmaceuticals-sangamo-therapeutics-anaptysbio", "https://www.nasdaq.com/articles/march-23rd-options-now-available-acadia-pharmaceuticals-acad-2018-02-01", "https://www.nasdaq.com/articles/why-the-earnings-streak-will-continue-for-acadia-pharmaceuticals-acad-2017-12-26", "https://www.nasdaq.com/articles/minerva-initiates-phase-iii-study-on-schizophrenia-candidate-2017-12-20", "https://www.nasdaq.com/articles/first-week-acad-february-2018-options-trading-2017-12-20", "https://www.nasdaq.com/articles/therapeuticsmd-falls-despite-acceptance-of-nda%3A-heres-why-2017-12-20", "https://www.nasdaq.com/articles/shires-new-formulation-of-oncaspar-gets-approval-in-europe-2017-12-14", "https://www.nasdaq.com/articles/glaxos-nucala-label-expansion-application-gets-fda-approval-2017-12-13", "https://www.nasdaq.com/articles/proteostasis-stock-surges-on-positive-data-from-cf-studies-2017-12-13", "https://www.nasdaq.com/articles/4-biotech-stocks-ready-to-crush-the-market-in-2018-2017-12-27", "https://www.nasdaq.com/articles/why-the-earnings-streak-will-continue-for-acadia-pharmaceuticals-acad-2017-12-26", "https://www.nasdaq.com/articles/minerva-initiates-phase-iii-study-on-schizophrenia-candidate-2017-12-20", "https://www.nasdaq.com/articles/first-week-acad-february-2018-options-trading-2017-12-20", "https://www.nasdaq.com/articles/therapeuticsmd-falls-despite-acceptance-of-nda%3A-heres-why-2017-12-20", "https://www.nasdaq.com/articles/acad-january-2018-options-begin-trading-2017-11-22", "https://www.nasdaq.com/articles/analysts-anticipate-21-upside-holdings-bbh-2017-11-20", "https://www.nasdaq.com/articles/better-buy-acadia-pharmaceuticals-vs-biogen-2017-11-11", "https://www.nasdaq.com/articles/lilly-reports-mixed-results-from-late-stage-cyramza-study-2017-12-11", "https://www.nasdaq.com/articles/5-cheap-biotech-stocks-snag-bounce-2017-12-08", "https://www.nasdaq.com/articles/heres-how-acadia-pharmaceuticals-crushed-it-2017-2017-12-04", "https://www.nasdaq.com/articles/medicines-company-to-sell-infectious-disease-unit-to-melinta-2017-11-30", "https://www.nasdaq.com/articles/spectrum-doubles-in-3-months%3A-whats-driving-the-rally-2017-11-27", "https://www.nasdaq.com/articles/is-a-beat-in-the-cards-for-perrigo-prgo-in-q3-earnings-2017-11-03", "https://www.nasdaq.com/articles/whats-in-the-cards-for-adverum-advm-this-earnings-season-2017-11-03", "https://www.nasdaq.com/articles/acadia-pharmaceuticals-scores-relative-strength-rating-upgrade-hits-key-threshold-2017-11", "https://www.nasdaq.com/articles/acadia-pharmaceuticals-now-oversold-acad-2017-11-08", "https://www.nasdaq.com/articles/how-invest-biotech-stocks-2017-11-08", "https://www.nasdaq.com/articles/nektar-acadia-pop-street-crushing-quarters-tesaro-dips-2017-11-07", "https://www.nasdaq.com/articles/earnings-reaction-history-acadia-pharmaceuticals-inc-625-follow-through-indicator-70", "https://www.nasdaq.com/articles/acadia-pharmaceuticals-breaks-below-200-day-moving-average-notable-acad-2017-11-06", "https://www.nasdaq.com/articles/whats-in-the-cards-for-prothena-prta-in-q3-earnings-2017-10-31", "https://www.nasdaq.com/articles/what-to-expect-from-keryx-kerx-this-earnings-season-2017-10-31", "https://www.nasdaq.com/articles/horizon-pharma-hznp-q3-earnings%3A-a-disappointment-in-store-revised-2017-11-02", "https://www.nasdaq.com/articles/whats-in-the-cards-for-arena-arna-this-earnings-season-2017-10-30", "https://www.nasdaq.com/articles/ball-corporation-bll-to-post-q3-earnings%3A-what-to-expect-2017-10-30", "https://www.nasdaq.com/articles/implied-fxh-analyst-target-price-74-2017-10-19", "https://www.nasdaq.com/articles/lillys-verzenio-gets-priority-review-in-first-line-setting-2017-10-13", "https://www.nasdaq.com/articles/heres-why-intercept-icpt-stock-lost-37-so-far-in-2017-2017-10-12", "https://www.nasdaq.com/articles/allergans-uterine-fibroids-candidates-nda-accepted-by-fda-2017-10-11", "https://www.nasdaq.com/articles/why-should-you-invest-in-novo-nordisk-nvo-stock-right-now-2017-10-10", "https://www.nasdaq.com/articles/is-a-beat-in-store-for-zoetis-zts-this-earnings-season-2017-10-30", "https://www.nasdaq.com/articles/whats-in-the-cards-for-arena-arna-this-earnings-season-2017-10-30", "https://www.nasdaq.com/articles/ball-corporation-bll-to-post-q3-earnings%3A-what-to-expect-2017-10-30", "https://www.nasdaq.com/articles/roche-rhhby-receives-fda-approval-for-cobas-zika-test-2017-10-09", "https://www.nasdaq.com/articles/biotech-rockets-then-dips-after-fda-breakthrough-win-2017-10-05", "https://www.nasdaq.com/articles/acadias-antipsychotic-drug-gets-breakthrough-therapy-status-2017-10-05", "https://www.nasdaq.com/articles/ligand-lgnd-signs-deal-to-acquire-crystal-bioscience-2017-10-05", "https://www.nasdaq.com/articles/morning-movers-constellation-brands-jumps-biogen-bounces-celgene-slips-2017-10-05", "https://www.nasdaq.com/articles/mallinckrodt-to-begin-sarcoidosis-study-on-acthar-gel-2017-10-10", "https://www.nasdaq.com/articles/emergent-completes-acquisition-of-anthrax-drug-raxibacumab-2017-10-04", "https://www.nasdaq.com/articles/2-stocks-move-after-hours-trading-2017-10-04", "https://www.nasdaq.com/articles/acadia-pharma-stock-rockets-drug-breakthrough-nod-2017-10-04", "https://www.nasdaq.com/articles/noteworthy-friday-option-activity-gra-ddd-acad-2017-09-29", "https://www.nasdaq.com/articles/allergan-authorizes-new-%242b-share-buyback-plan-stock-up-2017-09-26", "https://www.nasdaq.com/articles/commit-buy-acadia-pharmaceuticals-25-earn-82-using-options-2017-09-21", "https://www.nasdaq.com/articles/glaxo-innovivas-triple-combo-inhaler-positive-in-phase-iii-2017-09-21", "https://www.nasdaq.com/articles/celsions-immunotherapy-candidate-impresses-stock-surges-2017-10-04", "https://www.nasdaq.com/articles/supernus-drops-spn-810s-lower-dose-test-in-phase-iii-trials-2017-09-19", "https://www.nasdaq.com/articles/glaxo-innovivas-triple-combo-therapy-gets-fda-nod-for-copd-2017-09-19", "https://www.nasdaq.com/articles/biomarin-says-fda-not-planning-an-adcom-for-pegvaliase-bla-2017-09-18", "https://www.nasdaq.com/articles/math-shows-fbt-can-go-140-2017-09-15", "https://www.nasdaq.com/articles/alexion-alxn-reports-interim-results-for-soliris-study-2017-09-14", "https://www.nasdaq.com/articles/gtxs-gtxi-enobosarm-positive-in-phase-ii-shares-down-2017-09-14", "https://www.nasdaq.com/articles/perrigos-stock-up-starboards-ceo-calls-it-a-key-pick-2017-09-13", "https://www.nasdaq.com/articles/billionaires-are-gobbling-beaten-down-biotech-stock-should-you-2017-09-21", "https://www.nasdaq.com/articles/supernus-drops-spn-810s-lower-dose-test-in-phase-iii-trials-2017-09-19", "https://www.nasdaq.com/articles/glaxo-innovivas-triple-combo-therapy-gets-fda-nod-for-copd-2017-09-19", "https://www.nasdaq.com/articles/biomarin-says-fda-not-planning-an-adcom-for-pegvaliase-bla-2017-09-18", "https://www.nasdaq.com/articles/math-shows-fbt-can-go-140-2017-09-15", "https://www.nasdaq.com/articles/alexion-alxn-reports-interim-results-for-soliris-study-2017-09-14", "https://www.nasdaq.com/articles/gtxs-gtxi-enobosarm-positive-in-phase-ii-shares-down-2017-09-14", "https://www.nasdaq.com/articles/antheras-blisibimod-positive-in-phase-ii-extension-study-2017-08-29", "https://www.nasdaq.com/articles/marinus-stock-surges-on-successful-phase-ii-epilepsy-study-2017-09-12", "https://www.nasdaq.com/articles/jjs-jnj-xarelto-aspirin-regimen-positive-in-phase-iii-2017-08-28", "https://www.nasdaq.com/articles/minerva-jjs-amendment-of-min-202-contract-wins-eu-approval-2017-08-28", "https://www.nasdaq.com/articles/3-stocks-turned-8000-least-138000-5-years-2017-08-27", "https://www.nasdaq.com/articles/adamas-adms-dyskinesia-drug-gets-fda-approval-stock-soars-2017-08-25", "https://www.nasdaq.com/articles/ultragenyx-files-bla-to-fda-for-hypophosphatemia-candidate-2017-08-25", "https://www.nasdaq.com/articles/kite-pharma-at-new-52-week-high%3A-whats-driving-the-stock-2017-08-24", "https://www.nasdaq.com/articles/ultragenyx-rare-posts-disappointing-phase-iii-ace-er-data-2017-08-23", "https://www.nasdaq.com/articles/the-medicines-cos-inclisiran-positive-in-extension-study-2017-08-29", "https://www.nasdaq.com/articles/jjs-jnj-xarelto-aspirin-regimen-positive-in-phase-iii-2017-08-28", "https://www.nasdaq.com/articles/minerva-jjs-amendment-of-min-202-contract-wins-eu-approval-2017-08-28", "https://www.nasdaq.com/articles/gerons-gern-imetelstat-progressing-well-setbacks-concern-2017-08-14", "https://www.nasdaq.com/articles/analysts-forecast-10-gains-ahead-vxf-2017-08-14", "https://www.nasdaq.com/articles/heres-why-acadia-pharmaceuticals-inc-soaring-today-2017-08-09", "https://www.nasdaq.com/articles/drug-stocks-q2-earnings-roster-for-aug-8%3A-acad-jazz-more-2017-08-07", "https://www.nasdaq.com/articles/will-acadia-acad-pull-off-a-surprise-this-earnings-season-2017-08-02", "https://www.nasdaq.com/articles/jazz-pharmaceuticals-arm-announces-%24500m-senior-notes-offer-2017-08-18", "https://www.nasdaq.com/articles/math-shows-bbh-can-go-140-2017-07-12", "https://www.nasdaq.com/articles/minerva-on-track-to-initiate-phase-iii-schizophrenia-study-2017-06-26", "https://www.nasdaq.com/articles/3-biotech-stocks-enterprising-investors-2017-06-23", "https://www.nasdaq.com/articles/3-value-stocks-you-havent-thought-2017-06-19", "https://www.nasdaq.com/articles/baker-bros-advisors-lp-buys-incyte-corp-avexis-inc-la-jolla-pharmaceutical-co-sells-abbvie", "https://www.nasdaq.com/articles/sum-pieces-bbh-could-be-worth-138-2017-06-06", "https://www.nasdaq.com/articles/wednesdays-etf-movers-gdxj-bbh-2017-05-10", "https://www.nasdaq.com/articles/these-2-companies-have-no-competition-2017-07-18", "https://www.nasdaq.com/articles/mid-day-market-update-crude-oil-down-3-proteon-therapeutics-shares-spike-higher-2017-05-10", "https://www.nasdaq.com/articles/why-acadia-pharmaceuticals-inc-plunging-today-2017-05-10", "https://www.nasdaq.com/articles/analysts-forecast-12-upside-bbh-2017-05-04", "https://www.nasdaq.com/articles/whats-in-the-cards-for-acadia-acad-this-earnings-season-2017-05-02", "https://www.nasdaq.com/articles/acadia-pharmaceuticals-may-just-be-best-long-term-play-alzheimers-disease-treatment-market", "https://www.nasdaq.com/articles/acadia-pharmaceuticals-becomes-oversold-acad-2017-04-05", "https://www.nasdaq.com/articles/implied-iyh-analyst-target-price-171-2017-04-03", "https://www.nasdaq.com/articles/oversold-conditions-acadia-pharmaceuticals-acad-2017-05-10", "https://www.nasdaq.com/articles/mid-day-market-update-crude-oil-down-3-proteon-therapeutics-shares-spike-higher-2017-05-10", "https://www.nasdaq.com/articles/why-acadia-pharmaceuticals-inc-plunging-today-2017-05-10", "https://www.nasdaq.com/articles/analysts-forecast-12-upside-bbh-2017-05-04", "https://www.nasdaq.com/articles/whats-in-the-cards-for-acadia-acad-this-earnings-season-2017-05-02", "https://www.nasdaq.com/articles/acadia-pharmaceuticals-may-just-be-best-long-term-play-alzheimers-disease-treatment-market", "https://www.nasdaq.com/articles/acadia-pharmaceuticals-becomes-oversold-acad-2017-04-05", "https://www.nasdaq.com/articles/implied-iyh-analyst-target-price-171-2017-04-03", "https://www.nasdaq.com/articles/oversold-conditions-acadia-pharmaceuticals-acad-2017-05-10", "https://www.nasdaq.com/articles/analysts-expect-bbh-will-reach-134-2017-03-02", "https://www.nasdaq.com/articles/earnings-reaction-history-acadia-pharmaceuticals-inc-500-follow-through-indicator-59", "https://www.nasdaq.com/articles/after-hours-earnings-report-february-28-2017-crm-rost-panw-uhs-tsro-jazz-ar-dxcm-epr-logm", "https://www.nasdaq.com/articles/3-earnings-reports-that-should-be-on-your-radar-2017-02-24", "https://www.nasdaq.com/articles/acadia-pharma-acad-q4-earnings%3A-whats-in-store-this-time-2017-02-23", "https://www.nasdaq.com/articles/first-week-april-21st-options-trading-acadia-pharmaceuticals-2017-02-22", "https://www.nasdaq.com/articles/fbt-acad-alny-kite-etf-outflow-alert-2017-02-21", "https://www.nasdaq.com/articles/3-top-biotech-stocks-buy-2017-2017-03-26", "https://www.nasdaq.com/articles/potential-20-billion-indication-2-must-have-biotechs-taking-alzheimers-disease-2017-02-11", "https://www.nasdaq.com/articles/notable-etf-inflow-detected-xbi-clvs-acad-uthr-2017-02-02", "https://www.nasdaq.com/articles/forget-gw-pharmaceuticals-these-2-stocks-are-better-buys-2017-02-02", "https://www.nasdaq.com/articles/forget-anavex-life-sciences-corp-these-2-biotech-stocks-are-better-buys-2017-02-01", "https://www.nasdaq.com/articles/3-big-mergers-acquisitions-that-we-could-see-in-2017-2017-02-01", "https://www.nasdaq.com/articles/how-risky-acadia-pharmaceuticals-stock-2017-01-30", "https://www.nasdaq.com/articles/wednesdays-etf-unusual-volume-fnx-2017-01-04", "https://www.nasdaq.com/articles/top-biotech-stocks-buy-2017-2017-01-22", "https://www.nasdaq.com/articles/surprising-analyst-12-month-target-fbt-2017-01-19", "https://www.nasdaq.com/articles/why-acadia-pharmaceuticals-inc-stock-slipped-19-2016-2017-01-13", "https://www.nasdaq.com/articles/top-stocks-buy-2017-2017-01-07", "https://www.nasdaq.com/articles/3-companies-whose-sales-could-double-2017-2017-01-07", "https://www.nasdaq.com/articles/acadia-pharmaceuticals-inc.-acad-flirts-with-a-pfizer-inc.-pfe-buyout-2017-01-04", "https://www.nasdaq.com/articles/4-biotech-stocks-buy-january-2016-12-26", "https://www.nasdaq.com/articles/3-companies-whose-revenue-could-double-2017-2016-12-23", "https://www.nasdaq.com/articles/wednesdays-etf-movers-xbi-xle-2017-01-04", "https://www.nasdaq.com/articles/wall-street-sees-higher-open-uncertainty-looms-after-terror-attacks-berlin-zurich-ankara", "https://www.nasdaq.com/articles/health-care-sector-update-12202016-bmy-acad-jnj-pfe-abt-mrk-amgn-2016-12-20", "https://www.nasdaq.com/articles/pre-market-most-active-dec-20-2016-azn-acad-rad-cnat-abb-bac-gfi-mo-tvix-bbry-nvda-xiv", "https://www.nasdaq.com/articles/us-futures-point-north-uncertainty-looms-after-terror-attacks-berlin-zurich-ankara-2016-12", "https://www.nasdaq.com/articles/why-acadia-pharmaceuticals-inc-soaring-today-2016-12-20", "https://www.nasdaq.com/articles/acadia-pharmaceuticals-incs-stock-has-fallen-27-2016-have-we-hit-bottom-2016-12-19", "https://www.nasdaq.com/articles/3-beaten-biotech-stocks-are-they-bargains-2016-12-09", "https://www.nasdaq.com/articles/acadia-phase-ii-alzheimers-drug-hits-primary-endpoint-2016-12-21", "https://www.nasdaq.com/articles/5-biotech-stocks-george-soros-buying-2016-11-22", "https://www.nasdaq.com/articles/ready-get-biotech-check-out-these-3-stocks-2016-11-20", "https://www.nasdaq.com/articles/acadia-starts-phase-ii-schizophrenia-study-on-pimavanserin-2016-11-16", "https://www.nasdaq.com/articles/acad-crosses-above-key-moving-average-level-2016-11-10", "https://www.nasdaq.com/articles/why-acadia-pharmaceuticals-stock-surging-today-2016-11-08", "https://www.nasdaq.com/articles/heres-what-caused-acadia-pharmaceuticals-drop-27-october-2016-11-08", "https://www.nasdaq.com/articles/health-care-sector-update-11082016-acadosirbios-2016-11-08", "https://www.nasdaq.com/articles/3-biotechs-save-date-catalysts-tap-2016-11-29", "https://www.nasdaq.com/articles/drug-stocks-earnings-roster-for-nov-7%3A-hznp-acad-more-2016-11-04", "https://www.nasdaq.com/articles/what-to-expect-from-repros-rprx-this-earnings-season-2016-11-04", "https://www.nasdaq.com/articles/will-juno-therapeutics-juno-disappoint-in-q3-earnings-2016-11-03", "https://www.nasdaq.com/articles/what-to-expect-from-repros-rprx-this-earnings-season-2016-11-03", "https://www.nasdaq.com/articles/puma-biotechnology-pbyi-q3-earnings%3A-whats-in-store-2016-11-03", "https://www.nasdaq.com/articles/acadia-pharma-acad%3A-will-it-disappoint-in-q3-earnings-2016-10-31", "https://www.nasdaq.com/articles/3-charts-show-why-buy-acadia-pharmaceuticals-stock-2016-10-28", "https://www.nasdaq.com/articles/earnings-reaction-history-acadia-pharmaceuticals-inc-429-follow-through-indicator-50", "https://www.nasdaq.com/articles/commit-purchase-acadia-pharmaceuticals-20-earn-451-annualized-using-options-2016-10-19", "https://www.nasdaq.com/articles/implied-analyst-12-month-target-iwr-2016-10-10", "https://www.nasdaq.com/articles/these-2-biotechs-could-vanish-2018-2016-10-06", "https://www.nasdaq.com/articles/acadia-pharmaceuticals-enters-oversold-territory-acad-2016-10-05", "https://www.nasdaq.com/articles/notable-two-hundred-day-moving-average-cross-acad-2016-10-04", "https://www.nasdaq.com/articles/10-biotech-stocks-to-put-on-your-radar-this-quarter-2016-10-03", "https://www.nasdaq.com/articles/3-top-biotech-stocks-buy-october-2016-10-02", "https://www.nasdaq.com/articles/acadia-pharmaceuticals-becomes-oversold-2016-10-27", "https://www.nasdaq.com/articles/why-acadia-pharmaceuticals-tumbled-133-august-2016-09-11", "https://www.nasdaq.com/articles/3-stocks-begging-buyout-2016-09-11", "https://www.nasdaq.com/articles/3-mid-cap-healthcare-stocks-you-can-buy-right-now-2016-09-10", "https://www.nasdaq.com/articles/better-buy-acadia-pharmaceuticals-inc-vs-sarepta-therapeutics-inc-2016-09-03", "https://www.nasdaq.com/articles/3-stocks-could-make-you-rich-2016-08-31", "https://www.nasdaq.com/articles/3-stocks-over-1000-past-5-years-2016-08-28", "https://www.nasdaq.com/articles/3-biotech-stocks-explosive-upside-potential-2016-08-23", "https://www.nasdaq.com/articles/critical-couple-months-acadia-pharmaceuticals-2016-09-22", "https://www.nasdaq.com/articles/why-acadia-pharmaceuticals-tumbled-133-august-2016-09-11", "https://www.nasdaq.com/articles/3-stocks-begging-buyout-2016-09-11", "https://www.nasdaq.com/articles/3-mid-cap-healthcare-stocks-you-can-buy-right-now-2016-09-10", "https://www.nasdaq.com/articles/5-drug-stocks-to-watch-for-earnings-on-aug-4%3A-bmrn-more-2016-08-03", "https://www.nasdaq.com/articles/acadia-acad-q2-earnings-whats-store-stock-2016-08-02", "https://www.nasdaq.com/articles/these-3-biotechs-have-automatic-demand-2016-07-23", "https://www.nasdaq.com/articles/wednesdays-etf-movers-xbi-gdxj-2016-07-20", "https://www.nasdaq.com/articles/the-10-best-small-and-mid-cap-stocks-to-buy-now-2016-08-19", "https://www.nasdaq.com/articles/could-be-next-big-pharma-buyout-2016-07-18", "https://www.nasdaq.com/articles/3-risky-biotech-stocks-could-make-you-rich-2016-07-12", "https://www.nasdaq.com/articles/acadia-pharmaceuticals-inc-why-acad-stock-will-be-volatile-over-next-year-2016-07-05", "https://www.nasdaq.com/articles/these-3-biotech-stocks-are-ridiculously-cheap-now-2016-07-05", "https://www.nasdaq.com/articles/acadia-pharmaceuticals-incs-shareholders-are-having-crazy-year-heres-why-2016-06-28", "https://www.nasdaq.com/articles/noteworthy-etf-inflows-xbi-acad-anac-mdvn-2016-06-15", "https://www.nasdaq.com/articles/acadia-pharmaceuticals-stock-still-buy-2016-06-12", "https://www.nasdaq.com/articles/commit-buy-acadia-pharmaceuticals-18-earn-114-using-options-2016-07-19", "https://www.nasdaq.com/articles/notable-etf-inflow-detected-xbi-acad-anac-mdvn-2016-06-06", "https://www.nasdaq.com/articles/why-shares-acadia-pharmaceuticals-inc-jumped-today-2016-06-06", "https://www.nasdaq.com/articles/noteworthy-monday-option-activity-eat-acad-lnkd-2016-06-06", "https://www.nasdaq.com/articles/how-parts-add-iyy-headed-115-2016-05-31", "https://www.nasdaq.com/articles/xbi-acad-mdvn-anac-large-inflows-detected-etf-2016-05-26", "https://www.nasdaq.com/articles/the-10-best-healthcare-stocks-to-buy-now-2016-05-24", "https://www.nasdaq.com/articles/bullish-two-hundred-day-moving-average-cross-acad-2016-05-17", "https://www.nasdaq.com/articles/acadia-pharmaceuticals-inc-7-companies-could-buy-acad-2016-06-08", "https://www.nasdaq.com/articles/notable-etf-inflow-detected-xbi-acad-anac-mdvn-2016-06-06", "https://www.nasdaq.com/articles/why-shares-acadia-pharmaceuticals-inc-jumped-today-2016-06-06", "https://www.nasdaq.com/articles/noteworthy-monday-option-activity-eat-acad-lnkd-2016-06-06", "https://www.nasdaq.com/articles/how-parts-add-iyy-headed-115-2016-05-31", "https://www.nasdaq.com/articles/xbi-acad-mdvn-anac-large-inflows-detected-etf-2016-05-26", "https://www.nasdaq.com/articles/vti-vis-acad-cphd-large-inflows-detected-etf-2016-04-21", "https://www.nasdaq.com/articles/notable-etf-outflow-detected-vti-vis-acad-cphd-2016-05-11", "https://www.nasdaq.com/articles/spdr-sp-biotech-etf-experiences-big-inflow-2016-04-13", "https://www.nasdaq.com/articles/3-charts-explain-acadia-pharmaceuticals-inc-stock-2016-04-10", "https://www.nasdaq.com/articles/3-stocks-smartest-investors-are-buying-now-2016-04-09", "https://www.nasdaq.com/articles/why-acadia-pharmaceuticals-inc-skyrocketed-46-higher-march-2016-04-08", "https://www.nasdaq.com/articles/heres-why-sarepta-therapeutics-jumped-today-2016-04-06", "https://www.nasdaq.com/articles/spdr-sp-biotech-etf-experiences-big-outflow-2016-04-05", "https://www.nasdaq.com/articles/these-4-healthcare-stocks-are-all-soaring-today-and-heres-why-2016-04-04", "https://www.nasdaq.com/articles/3-stocks-could-double-your-money-2016-04-18", "https://www.nasdaq.com/articles/spdr-sp-biotech-etf-experiences-big-inflow-2016-04-13", "https://www.nasdaq.com/articles/midday-update-wall-street-still-building-post-yellen-gains-dow-hits-new-high-2016-2016-03", "https://www.nasdaq.com/articles/mid-day-market-update-acadia-pharmaceuticals-rises-following-fda-panel-vote-verint-systems", "https://www.nasdaq.com/articles/why-acadia-pharmaceuticals-stock-rocketing-higher-today-2016-03-30", "https://www.nasdaq.com/articles/us-stocks-eye-higher-open-yellen-remarks-adp-report-shows-200000-jobs-added-march-2016-03", "https://www.nasdaq.com/articles/pre-market-most-active-mar-30-2016-stor-ete-fcau-bac-nok-rig-acad-tvix-aapl-yhoo-vod-fb", "https://www.nasdaq.com/articles/why-lululemon-athletica-interoil-and-acadia-pharmaceuticals-jumped-today-2016-03-30", "https://www.nasdaq.com/articles/could-be-next-big-pharma-buyout-2016-04-03", "https://www.nasdaq.com/articles/midday-update-stocks-inching-higher-after-mixed-data-sliding-oil-price-encourages-caution", "https://www.nasdaq.com/articles/heres-why-acadia-pharmaceuticals-stock-soaring-today-2016-03-28", "https://www.nasdaq.com/articles/pre-market-most-active-mar-28-2016-acad-spil-tvix-fcx-xiv-fb-bac-vrx-yhoo-twtr-pbr-chk", "https://www.nasdaq.com/articles/why-did-acadia-pharma-acad-gained-17-day-2016-03-28", "https://www.nasdaq.com/articles/mid-afternoon-market-update-dow-jumps-50-points-pandora-shares-slide-2016-03-28", "https://www.nasdaq.com/articles/mid-afternoon-market-update-us-stocks-gain-markit-shares-surge-2016-03-21", "https://www.nasdaq.com/articles/notable-friday-option-activity-airm-acad-syk-2016-03-18", "https://www.nasdaq.com/articles/us-futures-continue-higher-after-yellen-suggests-caution-rate-increase-2016-03-30", "https://www.nasdaq.com/articles/midday-update-stocks-inching-higher-after-mixed-data-sliding-oil-price-encourages-caution", "https://www.nasdaq.com/articles/heres-why-acadia-pharmaceuticals-stock-soaring-today-2016-03-28", "https://www.nasdaq.com/articles/pre-market-most-active-mar-28-2016-acad-spil-tvix-fcx-xiv-fb-bac-vrx-yhoo-twtr-pbr-chk", "https://www.nasdaq.com/articles/why-did-acadia-pharma-acad-gained-17-day-2016-03-28", "https://www.nasdaq.com/articles/baker-brothers-advisors-buys-acadia-shares-2016-01-12", "https://www.nasdaq.com/articles/commit-purchase-acadia-pharmaceuticals-18-earn-18-annualized-using-options-2016-01-11", "https://www.nasdaq.com/articles/surprising-analyst-12-month-target-iyh-2016-03-07", "https://www.nasdaq.com/articles/interesting-acad-put-and-call-options-january-2018-2015-11-16", "https://www.nasdaq.com/articles/health-care-sector-update-11022015-ttph-acad-ctmx-2015-11-02", "https://www.nasdaq.com/articles/why-acadia-pharmaceuticals-today-2015-11-02", "https://www.nasdaq.com/articles/noteworthy-monday-option-activity-lpla-acad-ecom-2015-11-02", "https://www.nasdaq.com/articles/oversold-conditions-acadia-pharmaceuticals-acad-2015-09-28", "https://www.nasdaq.com/articles/5-sell-ranked-biotechs-fell-more-5-today-2015-09-25", "https://www.nasdaq.com/articles/3-healthcare-stocks-could-add-spark-your-portfolio-2015-09-16", "https://www.nasdaq.com/articles/why-shares-acadia-pharmaceuticals-inc-fell-cliff-2016-01-07", "https://www.nasdaq.com/articles/interesting-acad-put-and-call-options-january-2018-2015-11-16", "https://www.nasdaq.com/articles/why-acadia-pharmaceuticals-acad-could-be-positioned-for-a-slump-2015-08-14", "https://www.nasdaq.com/articles/3-small-cap-biopharma-stocks-id-never-short-2015-08-12", "https://www.nasdaq.com/articles/acadia-pharmaceuticals-becomes-oversold-acad-2015-08-07", "https://www.nasdaq.com/articles/why-acadia-pharmaceuticals-inc-dropping-today-2015-08-07", "https://www.nasdaq.com/articles/why-acadia-pharmaceuticals-inc-jumped-17-july-2015-08-05", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-amgen-tetraphase-geron-alexion-and-acadia-2015-09-10", "https://www.nasdaq.com/articles/why-parkinsons-disease-focused-acadia-pharmaceuticals-soaring-today-2015-09-03", "https://www.nasdaq.com/articles/acadia-pharmaceuticals-acad-shares-cross-below-200-dma-2015-08-20", "https://www.nasdaq.com/articles/andreas-halvorsen-increases-stake-esperion-therapeutics-2015-06-30", "https://www.nasdaq.com/articles/pabrai-funds-2014-investor-meeting-notes-2015-06-30", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-johnson-johnson-astrazeneca-acadia-pharmaceuticals", "https://www.nasdaq.com/articles/acadia-pharmaceuticals-moves-market-cap-rank-passing-qep-resources-2015-05-11", "https://www.nasdaq.com/articles/3-stocks-could-double-your-money-2015-04-19", "https://www.nasdaq.com/articles/xlf-ubio-big-etf-inflows-2015-07-24", "https://www.nasdaq.com/articles/should-abbvie-inc-buy-acadia-pharmaceuticals-help-fight-parkinsons-disease-2015-04-08", "https://www.nasdaq.com/articles/healthcare-merger-monday-these-3-stocks-could-be-healthcares-next-buyout-targets-2015-03", "https://www.nasdaq.com/articles/1-clinical-stage-biotech-stock-could-make-you-millionaire-2015-03-29", "https://www.nasdaq.com/articles/first-week-may-15th-options-trading-acadia-pharmaceuticals-acad-2015-03-27", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-amgen-regeneron-nektar-acadia-and-pharmacyclics-press", "https://www.nasdaq.com/articles/exciting-biotech-isnt-built-last-2015-03-19", "https://www.nasdaq.com/articles/acadia-pharmaceuticals-acad-crumbles%3A-stock-falls-by-22.2-tale-of-the-tape-2015-03-13", "https://www.nasdaq.com/articles/health-care-sector-update-04162015-acad-rcpt-hznp-2015-04-16", "https://www.nasdaq.com/articles/should-abbvie-inc-buy-acadia-pharmaceuticals-help-fight-parkinsons-disease-2015-04-08", "https://www.nasdaq.com/articles/us-futures-point-higher-amid-lower-expected-jobless-claims-retail-sales-disappoint-2015-03", "https://www.nasdaq.com/articles/correction-us-futures-higher-ahead-weekly-jobless-claims-data-retail-sales-2015-03-12", "https://www.nasdaq.com/articles/pre-market-most-active-mar-12-2015-bac-ll-acad-hsbc-eqm-cybr-c-aapl-qqq-ko-amrn-tvix-2015", "https://www.nasdaq.com/articles/us-futures-mixed-ahead-weekly-jobless-claims-data-retail-sales-2015-03-12", "https://www.nasdaq.com/articles/after-hours-most-active-mar-11-2015-swks-msft-mms-fb-bac-petm-acad-hpq-intc-crc-evhc-htz", "https://www.nasdaq.com/articles/will-epizyme-epzm-miss-estimates-this-earnings-season-analyst-blog-2015-02-25", "https://www.nasdaq.com/articles/acadia-down-on-nuplazid-nda-delay-and-ceo-resignation-analyst-blog-2015-03-13", "https://www.nasdaq.com/articles/why-acadia-pharmaceuticals-inc-stock-crashed-2015-03-12", "https://www.nasdaq.com/articles/us-futures-point-higher-amid-lower-expected-jobless-claims-retail-sales-disappoint-2015-03", "https://www.nasdaq.com/articles/will-aegerion-aegr-miss-earnings-estimates-this-season-analyst-blog-2015-02-24", "https://www.nasdaq.com/articles/will-dexcom-dxcm-loss-better-estimates-this-earnings-analyst-blog-2015-02-23", "https://www.nasdaq.com/articles/will-wright-medical-wmgi-disappoint-earnings-again-in-q4-analyst-blog-2015-02-23", "https://www.nasdaq.com/articles/can-greatbatch-gb-keep-the-earnings-streak-alive-in-q4-analyst-blog-2015-02-20", "https://www.nasdaq.com/articles/ecolabs-ecl-q4-earnings%3A-will-it-disappoint-estimates-analyst-blog-2015-02-20", "https://www.nasdaq.com/articles/is-a-surprise-coming-for-acadia-pharmaceuticals-acad-this-earnings-season-tale-of-the-tape", "https://www.nasdaq.com/articles/will-allscripts-mdrx-surprise-earnings-estimates-in-q4-analyst-blog-2015-02-24", "https://www.nasdaq.com/articles/merrimack-pharmaceuticals-mack%3A-a-miss-this-earnings-analyst-blog-2015-02-24", "https://www.nasdaq.com/articles/will-aegerion-aegr-miss-earnings-estimates-this-season-analyst-blog-2015-02-24", "https://www.nasdaq.com/articles/will-dexcom-dxcm-loss-better-estimates-this-earnings-analyst-blog-2015-02-23", "https://www.nasdaq.com/articles/will-wright-medical-wmgi-disappoint-earnings-again-in-q4-analyst-blog-2015-02-23", "https://www.nasdaq.com/articles/qiagen-qgen-disappoints-with-q4-earnings-revenue-miss-analyst-blog-2015-01-30", "https://www.nasdaq.com/articles/can-the-uptrend-continue-for-acadia-pharmaceuticals-acad-tale-of-the-tape-2015-02-19", "https://www.nasdaq.com/articles/after-hours-earnings-report-november-10-2014-rax-dei-wwd-praa-npsp-cib-acad-atw-atls-czr", "https://www.nasdaq.com/articles/first-week-june-2015-options-trading-acadia-pharmaceuticals-acad-2014-10-23", "https://www.nasdaq.com/articles/3-stocks-ill-buy-if-market-crashes-2014-10-20", "https://www.nasdaq.com/articles/acad-makes-bullish-cross-above-critical-moving-average-2014-07-01", "https://www.nasdaq.com/articles/fridays-etf-movers-fnx-xbi-2014-06-27", "https://www.nasdaq.com/articles/immunocellular-plans-move-ict-107-forward-phase-iii-trials-based-new-sub-group-analysis", "https://www.nasdaq.com/articles/notable-two-hundred-day-moving-average-cross-acad-2014-03-25", "https://www.nasdaq.com/articles/first-week-september-18th-options-trading-acadia-pharmaceuticals-acad-2015-01-23", "https://www.nasdaq.com/articles/fridays-etf-movers-xbi-gdxj-2014-02-21", "https://www.nasdaq.com/articles/upside-biotech-cloud-materials-2014-01-20", "https://www.nasdaq.com/articles/sector-update-biotech-stocks-looking-strong-nasdaq-struggles-2013-12-02", "https://www.nasdaq.com/articles/sector-update-biotechs-almost-1-adding-nasdaqs-gain-2013-11-26", "https://www.nasdaq.com/articles/sector-update-biotech-stocks-getting-injection-buying-interest-2013-11-20", "https://www.nasdaq.com/articles/bulls-think-acadia-will-keep-running-2013-06-17", "https://www.nasdaq.com/articles/market-wrap-monday-june-10-stocks-little-changed-quiet-trade-2013-06-10", "https://www.nasdaq.com/articles/acadia-pharmaceuticals-acad-jumps%3A-stock-rises-17.3-tale-of-the-tape-2014-02-24", "https://www.nasdaq.com/articles/fridays-etf-movers-xbi-gdxj-2014-02-21", "https://www.nasdaq.com/articles/upside-biotech-cloud-materials-2014-01-20", "https://www.nasdaq.com/articles/mid-morning-market-update-markets-fall-yahoo-acquire-tumblr-2013-05-20", "https://www.nasdaq.com/articles/pre-market-most-active-may-15-2013-ainv-bac-spwr-siri-cvrr-bbry-nok-amtd-sne-rh-acad-tsla", "https://www.nasdaq.com/articles/benzinga-market-primer-tuesday-may-7-2013-05-07", "https://www.nasdaq.com/articles/whats-behind-call-activity-acadia-2013-04-18", "https://www.nasdaq.com/articles/weekly-cfo-sells-highlight-ko-kkd-pir-npsp-acad-2013-04-16", "https://www.nasdaq.com/articles/insider-buys-shares-mining-company-freeport-mcmoran-while-graphic-packaging-sees-sale-2013", "https://www.nasdaq.com/articles/mid-morning-market-update-markets-continue-march-upwards-pc-makers-get-blasted-2013-04-11", "https://www.nasdaq.com/articles/pre-market-most-active-apr-11-2013-pcs-rad-sgyp-infi-msft-acad-rlgy-qqq-ftnt-nok-bac-hpq", "https://www.nasdaq.com/articles/market-wrap-thursday-april-11-stock-market-rally-continues-2013-04-11", "https://www.nasdaq.com/articles/mid-afternoon-market-update-rite-aid-posts-massive-rally-while-hewlett-packard-takes-hit", "https://www.nasdaq.com/articles/mid-day-market-update-acadia-posts-massive-rally-amd-falls-2013-04-11", "https://www.nasdaq.com/articles/mid-morning-market-update-markets-tumble-oracle-posts-downbeat-results-2013-03-21", "https://www.nasdaq.com/articles/pre-market-most-active-mar-21-2013-nok-orcl-sny-bac-bbry-tot-acad-cwt-csco-awc-qqq-znga", "https://www.nasdaq.com/articles/mid-morning-market-update-markets-plummet-bad-data-rite-aid-continues-rally-2013-04-12", "https://www.nasdaq.com/articles/mid-afternoon-market-update-markets-remain-red-dryships-posts-strong-rally-2013-03-21", "https://www.nasdaq.com/articles/mid-day-market-update-herman-miller-surges-upbeat-earnings-scholastic-falls-2013-03-21", "https://www.nasdaq.com/articles/benzinga-market-primer-tuesday-march-12-2013-03-12", "https://www.nasdaq.com/articles/after-hours-earnings-report-march-12-2013-kw-dole-acad-gca-gnmk-avid-wsr-ktos-gern-acrx", "https://www.nasdaq.com/articles/pre-market-most-active-nov-27-2012-acad-rah-bac-fb-nok-sne-glw-sid-qqq-aapl-ebay-znga-2012", "https://www.nasdaq.com/articles/after-hours-most-active-nov-27-2012-acad-gmcr-cig-dish-efii-nok-t-bac-jef-msft-dtv-hal", "https://www.nasdaq.com/articles/zacks-1-rank-additions-for-wednesday-tale-of-the-tape-2012-01-25", "https://www.nasdaq.com/articles/market-wrap-thursday-march-21-stocks-give-back-wednesdays-gains-2013-03-21", "https://www.nasdaq.com/articles/zacks-1-rank-additions-for-thursday-tale-of-the-tape-2012-01-19", "https://www.nasdaq.com/articles/zacks-1-rank-additions-for-tuesday-tale-of-the-tape-2012-01-17", "https://www.nasdaq.com/articles/zacks-1-rank-additions-for-friday-tale-of-the-tape-2012-01-13", "https://www.nasdaq.com/articles/7-biotech-penny-stocks-buy-2011-06-29", "https://www.nasdaq.com/articles/zacks-1-rank-additions-for-monday-tale-of-the-tape-2012-01-23"], "Content": []}